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Abstract 
Negative health behaviour during the period of adolescence contributes to the global burden 
of mortality, chronic disease, and preventable disability from physical injury. It is therefore 
essential to encourage positive health behaviour such as on-time vaccination, safer sex 
practices, and early recognition of infectious conditions and mental illness, before 
complications arise from unprotected sexual debut or undetected illness. 
Our project aims to determine the favourable aspects of global mHealth interventions as 
applied to adolescent health outcomes for knowledge transfer to adolescent infectious 
disease programmes in low and middle-income countries (LMIC’s). mHealth refers to the 
integration of mobile or wireless technology for health delivery and promotion and may 
appeal to adolescents as it allows for interactive, personalized, two-way communication on 
various digital platforms. However, it remains unclear what specific interventions work best 
to target vulnerable adolescents in LMIC’s, as most of the evidence for mHealth stems from 
studies in high-income countries, conducted on groups other than adolescents such as 
caregivers, health workers and adult patients. 
This report is a scoping review examining the global evidence of mHealth efficacy for 
common adolescent conditions, in order to gain insight into the types of interventions that 
best target adolescents for biological and behavioural health outcomes. These insights will 
facilitate knowledge transfer for the implementation of adolescent mHealth infectious disease 
management, and identification of research gaps. We included published and unpublished 
studies between 31 January 1990 and 30 November 2017, with no language limitation. 
Primary studies included adolescents (defined as 10-19 years of age) of any gender, 
location, or ethnicity, with access to a mobile phone or wireless device used for a health-
related outcome. Studies reported on health outcomes of HIV, TB, vaccine-preventable 
disease, depression, suicide, road traffic accidents and substances other than tobacco use. 
Purely qualitative study designs and voice-only calls were excluded.  
Despite the potential appeal of mHealth among adolescents, there is unclear overall 
evidence for efficacy in this population. We had hoped that the adolescent period itself would 
allow generalisability of interventions. However, the variable reporting quality between 
studies, often without rich contextual descriptions, necessitate caution with interpretation of 
findings. This incomplete reporting also impacted on knowledge transfer at multiple levels, 
despite the use of study-specific guidelines. Our recommendations for future researchers 
would be to undertake adequately-powered studies among clearly defined age groups, and 
examine biological health outcomes for longer periods of follow-up. We also encourage 
researchers to use mHealth-specific guidelines such as the CONSORT-EHEALTH and 
mERA checklists to enable effective knowledge transfer and scaling of interventions. 
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Chapter 1: Introduction 
1.1 Background 
For decades, the focus of global public health initiatives has been on the health of infants, 
children and pregnant women that has led to an “epidemiological transition” of reduced all-
cause mortality in younger children and pregnant women (Sawyer, 2016). At the same time, 
adolescent health has been overlooked due to the assumption that this is the healthiest 
period of life (Blum, 2004; (Viner et al., 2011). However, many undiagnosed mental 
conditions and negative health behaviours (such as drunk-driving, substance use and 
unprotected sex), emerge during adolescence (Patton et al., 2012; Sawyer, 2016). These 
underpin later chronic disease or disability and limit full socio-economic independence in 
multiple ways (Das Gupta, 2014; WHO, 2013). Those adolescents with undiagnosed mental 
conditions are more at risk of being expelled or suspended from school, early pregnancy 
before completing their education, engaging in criminal behaviour, and illicit drug use (WHO, 
2014a; Gore et al., 2011). Almost all adult smokers started using tobacco regularly in 
adolescence. These risks and behaviours may also negatively impact the health and early 
childhood development of their potential children (Laski, 2015; Patton et al., 2012).  
Adolescents living in LMIC’s are most vulnerable, where high prevalence of infectious 
diseases such as HIV, tuberculosis (TB) and malaria consume limited health staff and 
budget resources (Uppada, 2016; Oosthuizen, 2008). Newer, promising infectious disease 
vaccines for HIV and TB target the period of adolescence rather than childhood (Harris et al., 
2016; da Costa, 2015). Many experts believe that this period may offer the greatest public 
health benefit through primary prevention, as it is a highly social age that potentiates 
infectious disease transmission. Critically, it also corresponds with period of waning 
immunity from childhood vaccines and missed boosters (Wiysonge, 2012; Stockwell, 2013). 
Although some of these vaccines are close to clinical registration, health systems may yet 
face implementation challenges as they begin to target immunisation and infectious disease 
control among this neglected demographic (Ginsberg, Ann M. et al., 2016). 
Adolescents pose unique health communication challenges due to their stage of neuro-
cognitive development (Viner et al., 2011). The limbic system, linked to emotion and reward, 
matures ahead of the pre-frontal cortex, which is linked to planning and logic (Casey, 2008). 
This results in a protracted period of vulnerable decision-making in which health promotion 
messages that emphasise rational content and future health benefit may appeal less than 
the immediacy of peer- or reward-driven messages (Patton, 2012; Sawyer, 2016). 
Information is therefore urgently needed on how best to engage adolescents in primary 
prevention efforts (Patton, 2016). 
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1.2 Problem identification 
“mHealth” refers to the integration of wireless technology into health systems for improved 
health outcomes and has become recognised for its positive impact on health education, 
communication and behaviour change (Gurman et al., 2012). With the fastest-growing use of 
mobile phones globally being amongst youth1, mHealth may be especially suited to 
adolescents for communication of positive health-related information (Agarwal, 2015). 
However, adolescents have been neglected as mHealth beneficiaries; the evidence base for 
improved mHealth outcomes comes from target groups such as caregivers, health 
professionals, and adult patients, mostly in high-income countries (Free C, 2013). Moreover, 
the same type of intervention may not have the same outcome when applied to another 
condition or setting.  
Public health experts have identified adolescent immunisation as potentially the most 
promising target age-group for elimination of infectious disease. Current focus is on 
immunisation coverage among this age-group with vaccines already available, requiring 
boosters, such as pertussis, influenza, meningitis, diphtheria and tetanus. However, 
identifying what has worked previously for improving health-seeking behaviour for common 
adolescent conditions will be vital when the long-awaited vaccines against TB, HIV and 
malaria become available to the public. This knowledge will be needed for effective 
implementation, and immunisation coverage among the adolescent demographic. Given the 
recent proliferation of mHealth initiatives targeted at adolescents, it would be useful to 
examine intervention successes and failures in order to understand what has worked, and 
why. These insights are expected to aid the design and implementation of adolescent 
mHealth infectious disease management frameworks in low and middle-income countries.  
1.3 Aim and research questions 
This study examined the global evidence for adolescent mHealth across selected conditions, 
by identifying the common features of effective interventions, in order to facilitate transfer of 
this knowledge to low and middle-income countries. 
The following research questions were addressed using published evidence, grey literature, 
as well as consultation with relevant health practitioners:  
1. What is the evidence for improved adolescent health outcomes using mHealth?  
  
                                                             
1The ages between 15-24 years.  
http://www.unesco.org/new/en/social-and-human-sciences/themes/youth/youth-definition 
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2. How do the interventions differ in terms of: 
a) Demographics 
b) Modalities 
c) Biological/clinical outcomes 
d) Behavioural outcomes? 
 
3. What are the implications of research question one and two for designing and 
implementing mHealth interventions for adolescents in LMIC’s? 
1.4 Rationale for a scoping review 
A scoping review is a relatively new and specific style of literature review. It was first referred 
to in 2001 by Mays and Poppay, although largely attributed to Arksey and O’Malley in a 2005 
International Journal of Social Research Methodology publication (Mays and Poppay, 2001; 
Arksey and O’Malley, 2005). Scoping reviews, although without exact definition or method, 
are done to “rapidly and systematically map key concepts underscoring a research area as 
well as the types and main sources of evidence” (Arksey and O’Malley, 2005). It is a method 
of knowledge synthesis that “examines the extent, range and nature” of existing research, so 
that the “findings may be summarised and disseminated”. Further, they may be done to 
“identify research gaps in the existing literature” (Arksey and O’Malley, 2005).  
Figure 1 depicts the framework for conducting scoping reviews as described in the literature 
(Arksey and O’Malley, 2005; Levac, 2010; Armstrong 2011). Mandatory steps taken in this 
review are: refining the research question (Stage 1), literature review and selection (Stages 
2 and 3), data extraction (Stage 4) and concise reporting of results (Stage 5). The last stage 
of consultation (Stage 6), although often skipped, is vital if the review is undertaken to inform 
health or economic policy (Khalil, 2016).  
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Figure 1 Scoping Review Framework 
Arksey and O’Malley invited researchers using the scoping process to publish on their 
experiences in order to advance the methodology. Multiple researchers since then have 
done so, commenting on their experiences as a multi-disciplinary team, the time it took for 
the review, and whether quality assessment was done, among others (Levac, 2010; Daudt, 
2013; Armstrong, 2011; Colquhoun, 2014; Peters et al., 2015a). The recent publications, 
which include a scoping review of more than 500 scoping reviews, are currently being used 
by the EQUATOR network to formalise scoping reporting guidelines which will be known as 
PRISMA-ScR2.  
Scoping reviews have been shown to be particularly useful when a research area is broad or 
variable, and has not yet been fully reviewed (Colquhoun, 2014; Peters et al., 2015b). They 
have therefore been done both to determine the feasibility of a full systematic review and in 
their own right to map the key concepts and evidence in a defined area or field (Levac, 
Colquhoun & O'Brien, 2010). A systematic review is accepted as the most rigorous form of 
knowledge synthesis in healthcare, as it uses “systematic and explicit methods to identify, 
select, critically appraise and analyse data from studies included in the review”. However, 
systematic reviews require a certain amount of published studies (preferably randomised 
controlled trials) of similar quality and study setting, in order to use the statistical method of 
                                                             
2http://www.equator-network.org/reporting-guidelines/prisma/ 
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meta-analysis to analyse and summarise the results (Guyatt et al., 2008). Cochrane-like 
systematic reviews may also not be the best approach for knowledge translation (Gough, 
Thomas & Oliver, 2012). This is especially so when examining complex and multi-
disciplinary knowledge synthesis questions, and attempting to explain the framework for 
intervention success. Our method of choice was therefore a scoping study, as we were 
uncertain of the amount of published literature available to answer relatively complex 
research questions. 
 
1.5 Overview of dissertation 
Chapter two defines key terms, and consists of the literature review addressing adolescent 
development, health promotion for adolescent global health, and mHealth technology. 
Chapter three describes the methods used to find and select primary studies, and how data 
was extracted and analysed in the review. Chapter four gives the results of the included 
studies using the PICO framework, with reference to the participants, setting, study design 
and target conditions. It discusses and analyses the findings of the research, as well as the 
limitations thereof. The dissertation concludes with chapter five, which consists of 
recommendations, implications for future research and a conclusion.  
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Chapter 2: Literature Review 
This chapter gives an overview of relevant literature related to adolescent development and 
mHealth, with definitions of commonly used terms. It also examines the state of adolescent 
global health, and concerns specific to low and middle-income countries.  
2.1 The digital divide 
The digital divide refers to the unequal access to technology between those of older age 
living in rural, less affluent communities and those who are younger, more urban, socially 
connected and relatively affluent (Ahmed et al., 2014, Dorsey & Topol, 2016). This often 
means that those who stand to benefit most from disruptive technologies, are least likely to 
use the technology. There remains, in the first instance, a digital divide between advanced 
economies and developing economies where the world is divided in terms of access to 
internet technology (Mechael, 2010). This is largely dependent on relative costs of data, 
infrastructure and ease of access. In 2017, the International Telecommunication Union (ITU), 
a branch of the UN dedicated to tracking access and usage of ICT globally, reported 
inequitable home internet access that decreased from 84% in advanced economies to 43% 
in developing economies. Least developed economies lagged furthest behind with only 15% 
home ICT access (ITU, 2017). This means that the vast majority of people in developing and 
least developed economies are reliant on access at work, schools or public spaces. 
On a deeper level, the digital divide describes how access to information is unequally 
distributed as regards demographics of age, location, affluence and social standing (Ashraf, 
2008; Wu, 2012). Those who are of older age living in rural, less affluent communities are 
‘information-poor’ compared to their younger, more urban, socially-connected and relatively 
affluent counterparts (Ahmed et al., 2014, Dorsey & Topol, 2016). The unequal flow of 
information is critical when one considers that much of the available information on 
education, health and employment is increasingly digitally distributed. As a result, those who 
stand to benefit most from disruptive technology may be least likely to use it. As far back as 
1997, the former UN secretary General summed this up by stating (Annan, quoted in UN, 
1997): 
“The new information and communication technologies are among the driving forces 
of globalisation. They are bringing people together, and bringing decision makers 
unprecedented new tools for development. At the same time, however, the gap 
between information “haves” and “have-nots” is widening, and there is a real danger 
that the world’s poor will be excluded from the emerging knowledge-based global 
economy.”  
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However, as mobile phone ownership grows globally, a new digital divide is emerging in the 
discrepancy between mobile phone and smartphone ownership, with adults more likely to 
own smartphones than youth (Lenhart, 2018). Smartphones, of all the wireless technologies, 
may be best suited to mHealth interventions as they are capable of supporting interactive 
websites, video, and mobile applications, while being compact and portable. In a recent 
global survey of adult smartphone ownership, none of the emerging and developing 
economies from the Africa region had ownership above 40% (ITU, 2017). Japan was the 
only one of eleven advanced economies with less than 40% smartphone ownership among 
adults (Lenhart, 2015). While 70% of the world’s youth are online globally, it remains that 9 
out of 10 adolescents without any internet access live in Asia, Africa or the Pacific region 
(ITU, 2017). 
2.2 mHealth 
Information and communication technology (ICT) through mobile phones, the internet, social 
networking sites and instant messaging have provided means to an expanded social 
environment (Black, 2011; Buhi, 2013). ICT disrupts the need for transport, access and 
proximity for communication or entertainment. Its potential in reaching vulnerable 
populations has led to rapid integration in health care delivery, especially in LMIC’s where 
mobile phone ownership has grown the most in the last decade (Wu & Raghupathi, 2012).  
This integration of mobile or wireless technology into healthcare and health systems for 
improved delivery, health promotion and outcomes is also known as mHealth (Curioso & 
Mechael, 2010). mHealth may include health information systems; clinical decision-making 
tools such as software applications or ‘apps’; reminder services; short message services 
(SMS) and telephone calls or any other wireless communication for the purpose of improving 
health implementation and outcomes (Aranda-Jan, Mohutsiwa-Dibe & Loukanova, 2014; 
Fortuin et al., 2016). Smartphones, of all the wireless technologies, may be best suited to 
mHealth interventions as they are capable of supporting interactive websites, video, and 
mobile applications, while being compact and portable.  
mHealth has been shown to be effective for a range of improved health outcomes that 
include disease surveillance, health information for patients, supply chain management, 
vaccine implementation and provider decision aids (Devi et al., 2015; Free C, 2013; Kalan et 
al., 2014; Oyo-Ita et al., 2016; Wiysonge et al., 2012). It has also been shown to be effective 
for adult HIV and TB disease management through improved adherence, visit reminders, 
education, communication of results, data collection and follow-up care (Devi et al., 2015). 
Adherence rates required to yield viral suppression and reduce drug resistance in conditions 
such as HIV and TB are 95% and 90% respectively. This poses immense challenges in 
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resource-limited settings, but may be viable due to the growing access to mobile phones 
globally and the cost- and time-saving benefits that have been shown with mHealth 
(Dempsey & Zimet, 2015). Owing to its low cost, ease of use, growing mobile phone 
ownership, and ability to deliver health messages directly to the target patient, the mHealth 
platform of engagement may be uniquely placed to impact adolescent health attitudes, 
behaviour and outcomes, even in rural areas (Buhi, 2013). 
Despite widespread acceptance of mHealth’s positive impact, it remains unclear what 
determines success in one country or disease setting, and failure in another. For example, 
the success of two-way SMS messaging for improved adherence to antiretroviral treatment 
reported in the WelTelKenya trial (Lester et al., 2010), has been replicated in a Canadian 
setting (King et al., 2017). Yet a similar, well-conducted randomised trial found no evidence 
for SMS messaging for drug-sensitive tuberculosis treatment adherence (Nglazi et al., 2013). 
This mHealth evidence base is similarly inconsistent for adolescents. For example, a US 
study of brief telephone counselling for adolescent girls aged 14-19 years showed sustained 
reductions in STI’s up to 36 months after the intervention (DiClemente, 2014). Yet a similar 
telephone intervention for contraception adherence showed no effect (Trent, 2015). mHealth 
also remains under-utilised and is rarely scaled to capacity in low and middle-income 
countries (Brinkel et al., 2014; Falzon et al., 2016; Hall et al., 2014).  
2.3 Adolescent development, communication and mHealth 
The World Health Organisation (WHO) defines “adolescents” as those aged 10–19 years, 
and “youth” as those aged 15-24 years (United Nations Department of Economic and Social 
Affairs, 2013), definitions to which this report will adhere. The transition from adolescence 
into healthy, productive adulthood requires access to health education, quality appropriate 
health services, and supportive home and community environments (Laski, 2015). However, 
negative attitudes towards exercise, nutrition and risk behaviour may persist into later life, 
adding to the global burden of chronic disease and disability, instead. In addition, undetected 
health conditions such as STI’s, depression, substance and tobacco use directly affect their 
health and the early childhood development of their potential children (Laski, 2015; Patton et 
al., 2012). Addressing their wellbeing becomes vital as this enables independence, 
completion of schooling with better employment options, and healthy relationships (Gore et 
al., 2011, Sawyer et al., 2012). Furthermore, encouraging positive adolescent health 
behaviour (such as on-time vaccination, safer sex practice, early recognition of infectious 
and mental illness) before complications arise is therefore essential. 
Adolescents pose health systems challenges in terms of engagement and positive health 
knowledge (Viner, 2011). In addition, they contribute unique communication challenges due 
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to their stage of neuro-cognitive development (Viner et al., 2011; Patton, 2012). The limbic 
system, linked to emotion and reward, matures ahead of the pre-frontal cortex, which is 
linked to planning and logic (Casey, 2008). This coincides with wide variations in peak levels 
of Dopamine, a regulatory neurotransmitter which balances activity between the various 
areas of the brain (Casey, 2008). Multiple social cognitive and functional brain imaging 
studies have shown that adolescents make clearer decisions when situations are 
hypothetical (Steyn, 2005 quoted in Casey, 2008). In contrast, when making decisions that 
involve conditions of stress, emotion or personal relevance, adolescents are more likely to 
respond according to their feelings (Steinberg, 2005 quoted in Casey, 2008). There is thus a 
difference in how adolescents perceive information which is “personal” to that which is 
“general or rational”. This difference in perception and processing is consistent with the 
adolescents’ relatively mature and dominant limbic system, yet still-developing prefrontal 
cortex. They may therefore make “poor decisions”, even when “knowing better”, in 
emotionally-charged situations. Eventual maturity of the pre-frontal cortex may be anywhere 
up to 25-30 years of age, with an interim protracted period of vulnerable decision-making 
and potential risk-taking behaviour (Casey, 2008). This highlights the importance of 
perceived stigma and peer group acceptance in this period of emotionally-reactive decision-
making until the prefrontal cortex matures (Patton, 2015).  
From a health promotion and delivery perspective, this means that rational content of 
communication may appeal less than peer- or reward-driven messages of personal benefit. 
The wireless, portable capabilities of mobile phones and smartphones allow for 
individualization, all of which have been attributed to the growing evidence for mHealth 
success. These capabilities may include targeting of messages (i.e. specific content sent to 
specific groups), tailoring (i.e. content relevant only to pre-specified goals or behaviours), 
personalization (i.e. sending information or content aligned to how one self-identifies by use 
of personal details, culture or group membership) as well as scheduling of message delivery 
and content to suit individuals (Reback et al., 2012). All of these features work to increase 
the personal relevance and appeal of health messages; it is postulated that when messages 
are perceived as personally relevant, they may be effective at persuading positive health 
behaviours. Smartphones are especially capable of supporting tailored mHealth 
interventions by accommodating web browsing, video features, chat functions and 
application software that older mobile phones cannot. 
As adolescents globally (regardless of country per-capita income or location) are the group 
with growing access to wireless technologies, these are theoretically well-suited for 
communication with them. Wireless technologies include WAP-enabled mobile phones, 
smartphones, tablets and laptops (Amacizia, 2013; Agarwal et al., 2015). Furthermore, 
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mHealth interventions transcend the need for in-person clinic attendance and may be 
especially suited to adolescents due to their convenience, confidentiality and potential 
personalisation in relaying health information. These aspects of mHealth may be especially 
beneficial in reaching males, younger adolescents before sexual debut, and those in LMIC’s 
i.e. those whose high burden of disease has been least impacted by global public health 
initiatives (Viner, 2011; WHO 2011).  
2.4 The state of adolescent global health 
In much the same way as countries have neglected the future economic potential of their 
adolescents over the past 50 years (Das Gupta et al., 2014), adolescents have been 
overlooked in global health initiatives due to the assumption that it is the healthiest period of 
their life (Blum, 2004). For example, half of all mental health disorders in adulthood start by 
age 14, but most cases are undetected, and therefore remain untreated. Those adolescents 
with undiagnosed mental conditions are more at risk of being expelled or suspended from 
school, falling pregnant before completing their education, and engaging in criminal 
behaviour and illicit drug use (WHO, 2014c; Gore et al., 2011). Despite the belief that they 
are ‘healthy’, adolescents face daily health risks from potentially unprotected sexual debut, 
social groupings potentiating infectious disease transmission, missed mental health 
diagnoses, and exposure to maladaptive coping strategies such as substance and alcohol 
use.  
Around 1.2 million adolescents died in 2015, more than 3000 per day. Most of these deaths 
were preventable or treatable (Mokdad et al., 2016; WHO, 2017). African and South-East 
Asian LMIC’s together constitute half of the global adolescent population, and also carry 
abouttwo thirds of all adolescent lives lost to death and disability in 2015 (WHO, 2017). 
Rates of adolescent mortality ranged from 243 deaths per 100 000 in African LMICs, to 24 
per 100 000 in high-income countries. Road traffic accidents caused the most adolescent 
deaths globally in 2015. Violence was the leading cause of death among older adolescent 
males, whereas older girls died from pregnancy-related complications. Depression ranked 
third as a cause of illness and disability among adolescents overall, and suicide was ranked 
third as a cause of death in older adolescents aged 15-19 years.  
More than 2 million adolescents are HIV-positive, and contrary to the decline in adult 
infections, adolescent HIV and STI infections are rising (WHO, 2017). US sexual health 
statistics show that adolescents account for 50% of all new STI’s diagnosed (Cornelius et al., 
2013). Most HIV-infected adolescents live in Sub-Saharan Africa, yet only 10-15% of them 
are aware of their HIV status. Minority Black, Hispanic and male adolescents constituted 
50% of all new HIV infections in the US ten years ago, and this has not reduced (Besoain, 
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2015; Gold, 2011). A 2008 Centres of Disease Control publication reported that younger 
men-who-have-sex-with-men (MSM) had a much higher false assumption of their own 
untested HIV status (Oluoch et al., 2015). Seventy-five percent of eighteen to nineteen year-
old MSM who believed themselves to be HIV negative, tested HIV positive. STI and HIV 
prevention curricula delivered in face-to-face sessions have been implemented effectively to 
reach adolescents in small groups and schools (Barry, 2016). However, the reach of this 
information needs to be extended outside of middle-school settings (Champion, 2017; Barry, 
2016). Target groups also need to include younger adolescent age groups; up to 70% of 
sexual debut among females occurs due to coercion, and under the age of fifteen years 
(Mustanski et al., 2014). 
The WHO’s Regional Strategic Plan for Africa (WHO/AFRO) and the Global Alliance for 
Vaccines and Immunisation (GAVI) have prioritised immunisation coverage, new vaccine 
development and health innovation in African countries (Bangure et al., 2015). Immunisation 
coverage refers to the ratio of vaccinated to unvaccinated individuals. By reducing the 
number of currently infectious people through reduced transmission, it indirectly protects 
even those with immature immune systems (elderly, infants, pregnant and immuno-
suppressed). Unfortunately, average coverage for various countries remains below most 
vaccine-preventable disease programme targets of 85-90%. Furthermore, decades have 
passed with the focus of global health bodies on immunisation coverage on infants and 
children. 
Adolescents were included in the WHO Global Strategy Report for the first time as recently 
as 2016 (Kuruvilla, 2016). This growing global commitment has been underpinned by the 
realisation that adolescents constitute the largest global demographic, about 1.2 billion 
people (WHO, 2017). As such, an effective adolescent immunisation programme would 
return huge dividends in reduced transmission of infectious disease. Adolescent health 
promotion efforts may reduce the growing burden of non-communicable disease and 
disability (Patton et al., 2016). When viewing the period of adolescence as a tipping point for 
chronic disease and disability later in life, its importance for public health is clear as regards 
early substance use, risky sexual activity and STI’s.  
Little attempt has been made to facilitate knowledge transfer from the mHealth interventions 
undertaken in high-income countries focused predominantly on lifestyle and mental health 
concerns to pressing LMIC needs such as infectious disease control. As regards infectious 
diseases, systematic reviews have addressed HIV and TB medication adherence among 
adults (Kalan et al., 2014; Smillie et al., 2014) or immunisation among children and infants. 
One recent review (Grist et al, 2017), addressing mHealth for adolescent mental health 
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found insufficient evidence for efficacy, given the limited sample sizes in 24 studies with 
variable reporting quality. Conversely, a growing number of recent systematic reviews have 
addressed adolescent lifestyle factors, diet and physical activity as modifiable risk factors for 
later chronic disease. Here, the evidence base is largely positive, is from well-reported 
studies although reporting periods could be extended (Rose, Barker et al 2017; McIntosh, 
2017). More pertinently, for the adolescent HIV, TB and malaria vaccines pending 
registration, no such published evidence exists outside of ongoing clinical trials. This gap in 
the evidence base may delay roll-out once such vaccines are registered, as health systems 
may find it challenging to target adolescents directly.  
A recent review conducted in Kenya has focused on knowledge transfer from HIV to chronic 
disease (Mbuagbaw, 2015). The commonalities between the disease conditions, setting and 
health infrastructure served as a basis for knowledge transfer from the extensive HIV 
evidence base to chronic disease, which is less well-researched in LMIC’s. By combining 
this element of commonality between the adolescent conditions, and the scoping ability to 
rapidly map the literature, we hope to derive meaningful insights for knowledge transfer to 
implement the adolescent vaccines pending registration in low and middle-income countries. 
Enabling positive adolescent health behaviour could have significant impact on such varied 
health outcomes as mental and reproductive health, infectious disease transmission, 
substance use and self-harm. Understanding and promoting health behaviour among 
adolescents is therefore essential because this group constitutes the future health and 
economic potential of especially low and middle-income countries (UNICEF, 2002; 
Wiysonge, 2012).  
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Chapter 3: Methods 
Conventional systematic reviews risk excluding large bodies of evidence due to stringent 
inclusion and exclusion criteria (Leon, Schneider & Daviaud, 2012). Our approach was 
therefore a scoping review, in order to include a broad range of relevant evidence for policy 
makers, disease control planners and health practitioners to understand and effectively 
implement adolescent mHealth interventions in their particular context. 
3.1 Criteria for considering studies for this review 
Our initial search included all studies targeting adolescents directly for a biological or 
behavioural health outcome, where the primary component being evaluated was an mHealth 
intervention. Behavioural outcomes described measures such as self-efficacy, therapeutic 
alliance with health providers, adherence to medication and change in risk behaviour; these 
were subjective and largely self-reported. Biological outcomes referred to clinical tests for 
diagnosis or monitoring of conditions, clinical cure or relapse rates, change in prevalence of 
the condition, on-time appointments and other findings that may be measured objectively. 
We examined mHealth interventions targeting the most common adolescent conditions, 
stated as being the four most common causes of disability and death in male and female 
adolescents according to the 2015 Global Burden of Disease Study (Mokdad et al., 2016). 
Target conditions covered the three broad categories of (i) reproductive health, (ii) mental 
health and injury, and (iii) infectious disease. The final target conditions differ from those 
stated in the protocol, as they were amended based on results of the initial title-abstract 
screening. Certain keywords returned high numbers of studies on participants outside of our 
defined age range without any studies being eligible on title-abstract screen. Examples of 
such keywords are ‘anaemia’, ‘smoking’, ‘malaria’, ‘PTSD’, ‘bipolar disorder’ and ‘anxiety’. 
These keywords were thus omitted in later search iterations. Table 1 summarises the 
changes through iterations, acceptable in the scoping process (but less desirable in 
systematic reviews). The first column contains keywords as originally stated in the study 
protocol and the last column shows those terms omitted during the search iterations. The 
central column contains the final search strategy target conditions. Studies with additional 
non-mHealth measures (such as health visits or counselling) that differed between the 
control and intervention groups, or used non-portable devices, were also excluded in later 
iterations. The initial and final search strategy may be found in Appendix 1.
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Table 1 Summary of the process of refinement of target conditions 
 
All initial target conditions by category 
Target conditions 
included in final search 
strategy 
Target conditions 
omitted in the final 
search strategy 
Infectious Disease: 
HIV  
TB 
Malaria 
Vaccine-preventable disease (VPD): influenza  
VPD: Human papilloma virus(HPV) 
 
HIV 
TB 
VPD: Influenza 
VPD: HPV 
 
Malaria 
Reproductive health 
Curable STI’s 
Contraception adherence 
Safer sex practice 
  
Mental Health and Injury: 
Depression 
Suicide  
Anxiety 
Bipolar Disorder 
Substances other than tobacco 
Smoking (tobacco) 
Road traffic accidents 
 
Depression 
Suicide  
Road traffic accidents 
Substances other than 
tobacco 
 
 
Anxiety 
Bipolar disorder 
PTSD  
Smoking (tobacco) 
Other Conditions 
Anaemia 
 
 
 
Anaemia 
 
3.1.1 Types of Studies 
Primary studies included were experimental (RCT’s, quasi-experimental), mixed-methods 
surveys or observational (descriptive or analytical) study designs. Purely qualitative studies 
were excluded to facilitate potential meta-analysis. Systematic reviews were excluded (as 
this was not a review of reviews), but their references were checked to ensure that no 
relevant primary studies were missed. No primary study population was included twice, but 
all eligible studies were read in conjunction with qualitative publications on the same study 
population. This was vital for understanding features such as participant demographics, 
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setting, message frequency and intervention technology; aspects sometimes not fully 
reported, but essential for knowledge transfer. 
3.1.2 Types of participants 
Primary studies included adolescents of any gender, location, or ethnicity with access to a 
mobile phone or wireless device used for a health-related outcome. The intervention had to 
target adolescents themselves; not schoolteachers, caregivers or other health providers. 
Included studies were required to report clearly on the mHealth modality used, and state the 
study objectives a priori.  
3.1.3 Types of interventions 
mHealth modalities included were applications, social networking sites, interactive websites, 
text messages, web-based interviews and counselling, compared to standard of care or 
another mHealth intervention. Although our initial intention was to include all wireless 
communication for the purpose of improving health implementation and outcomes, iterations 
through the scoping stages led us to exclude telephone calls, as they were not explicitly 
wireless technology and it proved difficult to objectively assess the features of a telephone 
call as an intervention. 
3.1.4 Review outcomes 
The outcome of this review is an assessment of whether mHealth improves management of 
the most common global adolescent conditions. This knowledge will inform how mHealth 
may be implemented for infectious disease management in low and middle-income 
countries. Secondary outcomes include identifying further research needs, and identifying 
opportunities for scaling up mHealth interventions in LMIC’s. 
3.2 Search Strategy 
Primary studies published in peer-reviewed journals with no language limitation, were 
extracted from the following electronic databases: PubMed (NLM), Scopus, CINAHL, 
EBSCO Host, Africa-Wide, PsychINFO, Web of Science (Thomson Reuters), Cochrane 
Library (including Cochrane Central Register of Controlled Trials (CENTRAL), Academic 
Search Premier, Communication and Mass Media Complete, Computer and Applied 
Sciences Complete and NHS Health Technology Assessment Database. Our search period 
was January 1990 to 30 November 2017.The initial search date was 27 May 2017; the final 
search for updates was run on 10 December 2017. 
The studies were selected using predefined search terms comprising both free text word and 
medical subject heading (MeSH) for PubMed, and adapted appropriately for other 
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databases. The search terms described mHealth, the adolescent population, and the 
amended target conditions. The search strategy was developed in consultation with a health 
sciences information specialist, and updated before the final search. The reference lists of 
identified systematic reviews were hand searched for relevant articles; NCBI citation index 
was used to identify relevant articles until no new citations for the search period were found. 
Unpublished sources were evaluated in the form of the WHO institutional website, as well as 
conference proceedings and abstracts.  
Criteria for study inclusion at the level of full-text review were:  
i) the intervention must target a "health outcome" which may be biological, subjective, or a 
health behaviour for at least one of the pre-defined conditions; 
ii) adolescents must be targeted directly, not through parents/caregivers/healthcare 
workers; 
iii) at least 50% of the sample must be between the age of 10-19 years; if a mean outside of 
this age range was reported the study authors were contacted to get age-disaggregated 
data; 
iv) experimental, mixed-methods or observational study designs; and 
v) conference abstracts and posters may be included if sufficient information about sample 
and findings are reported; 
An eligibility prompt tool was developed by the author based on earlier iterative searches, 
after noting incomplete reporting of sample ages, effect sizes and intervention features 
(Appendix 2).  
3.3 Study selection 
All articles identified in the search were screened by title and abstract and the full-text was 
drawn if relevant, or more information was needed. Endnote software manager was used to 
remove all duplicate material. The author and a second reviewer met for abstract and text 
review, and any disagreements were carried forward to the next round of screening. 
Disagreements were adjudicated by a third reviewer.  
3.4 Data extraction and management 
A data extraction form (Appendix 3) was piloted and refined on four primary studies across 
the various disciplines. The descriptive and outcome data were extracted by the author and 
checked by her primary supervisor, with any studies not meeting full consensus moved 
ahead to full-text review. The data extracted were: author, title, year of publication; number 
and type of included participants and subgroups as reported; target condition and countries 
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in which the primary studies were done; mHealth modality and wireless technology targeted; 
reporting quality regarding allocation concealment, blinding of outcome assessors, loss to 
follow-up, and other sources of bias.  
The author entered the final data into statistical software package (Cochrane Collaboration 
Review Manager Version 5.3). All data entries were then crosschecked independently by the 
information specialist before analysis. 
3.4.1 Dealing with missing data 
Authors of ten primary studies were contacted by email for clarification of age-disaggregated 
data, methods and details on how the intervention was accessed. Six studies were excluded 
due to non-response despite multiple attempts. 
3.4.2 Assessing methodological quality 
The quality assessment forms were piloted on four selected studies. The author and the 
information specialist independently assessed quality using an amended Cochrane Risk of 
Bias tool (Higgins, 2011). Blinding of interventions for outcome assessors was omitted from 
the standard Cochrane Risk of Bias tool, as it was not possible to assess allocation bias for 
most of the mHealth interventions.  
3.5 Data Analysis 
Meta-analysis, the statistical process of pooling comparable results to determine effect size, 
was undertaken. Pooling of data was conducted only on studies with low heterogeneity, as 
defined by an I-squared value of less than 50%. Heterogeneity refers to the degree of clinical 
and methodological variability between studies. It may be assessed as absent (below 25%), 
low (25-50%), medium (50-75%) or high (Alonso-Coello et al., 2016). Where studies show 
high heterogeneity once pooled, possible reasons for this are discussed. As the effect sizes 
reported between studies varied greatly, we grouped the effect measures by outcome 
variable. For dichotomous outcomes, we expressed the outcomes as risk ratios (RR) with a 
95% confidence interval. Continuous outcomes proved most challenging in analysis as they 
were reported in various ways. Where possible, where the same scale was used and post-
intervention means and standard deviations were reported, the mean difference (MD) and 
95% confidence interval was calculated using RevMan calculator. Where different scales 
were used to report effect sizes for the same outcomes, the standardised mean difference 
(SMD), was calculated. To check the results, the data was entered separately into statistical 
software programme, Comprehensive Meta-Analysis  version 3.1 (Borenstein et al., 2009). 
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The measures of effect per intervention are shown as a forest plot with 95% confidence 
intervals, where a p value of below 0.05 denotes statistical significance. Analyses were 
conducted using the random effects model unless specified otherwise, as it was unlikely that 
conditions were exactly the same across the various studies. Subgroup analyses were 
conducted by gender, sexual activity, target condition and modality of intervention.  
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Chapter 4: Results 
This section gives an overview of the studies included in the review, and highlights selected 
target conditions and subgroups (based on age, gender, and time points), before 
summarising the evidence with reference to the original research questions. A detailed 
narrative account of each individual mHealth intervention is beyond the scope of this thesis. 
4.1 Study flow 
We obtained 3498 studies in the initial search, which led to the iterative changes described 
previously in Section 3.1. 
A total of 452 studies were identified in the revised search. Four hundred and forty-two were 
published studies, and six studies were found through conference databases and grey 
literature. Four further studies were identified by hand-searching reference lists and 
systematic reviews. Two-hundred and forty-eight studies were screened by title-abstract, 
after removal of duplicates. 
Sixty-eight full-text articles remained after screening and were assessed for final eligibility. 
Forty-seven articles were excluded for the following reasons: non-adolescent study 
population (n=23), insufficient detail reported on health outcomes (n=8), other target 
condition (n=5); use of non-wireless technology (n=6); and other study designs (n=5).The 
studies retrieved by hand-searching the reference lists of systematic reviews found in the 
search were excluded due to participant ages. 
Twenty-two primary studies remained, which met all eligibility criteria. The majority of studies 
were experimental studies with small sample sizes consistent with pilot studies, 
predominantly in sexual and reproductive health. Twelve studies were RCT’s; there were 
equal numbers of observational and quasi-experimental studies (n=4), and two mixed-
methods surveys. 
Figure 2 depicts the study flow of screening, study selection as well as the number of 
publications extracted and retained at each step of the search (Moher et al., 2015). 
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Figure 2 PRISMA Diagram (Moher et al., 2015) 
 
Table 2 outlines the target conditions represented in the search results, and those amenable 
to narrative or statistical synthesis methods.
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 	
For	more	information,	visit	www.prisma-statement.org.	
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Table 2 Included studies: summary by target condition and type of evidence synthesis 
Meta-analysis Narrative synthesis Conditions not represented in evidence 
synthesis 
Reproductive health (n=6) 
Ybarraet al (2017) 
Lim et al(2012) 
Rokickiet al(2017) 
Scull et al (2017) 
Bull et al (2012) 
Trent et al(2015) 
 
Depression (n= 5) 
Ranney et al(2016) 
Manicavasagar et al(2014) 
Narring et al(2013) 
Branson et al (2013) 
Kobak(2015) 
 
Substances other than tobacco 
(n=1) 
Haug (2017) 
Reproductive health (n=5): 
Cornelius et al (2013) 
Matheson et al (2014) 
Brayboy (2017) 
Fiellin et al (2017) 
Juzang et al (2011) 
 
Substances other than tobacco 
(n=5) 
Jeffries et al (2017) 
Weitzel et al(2007) 
Larimer (2009) 
Tahaney et al (2017) 
Montanaro et al (2015) 
 
 
 
Infectious disease – TB 
Infectious disease – HIV * 
Suicide 
Road traffic accidents 
Vaccine-preventable disease: HPV 
Vaccine-preventable disease: Influenza 
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4.2 Details of included studies 
Twenty-two studies were included. All were published in English between 2007 and 2017. 
These studies covered conditions such as: mental health, substance and alcohol use, and 
infectious disease. They reported on knowledge, behavioural, or biological outcomes, or 
combinations thereof. Knowledge of STI’s and substance use was assessed by repeat 
questionnaire administered by primary study authors, with improvement reflected by an 
improved test score. Knowledge assessment studies totalled seven in number, and were 
excluded from the meta-analysis, due to published evidence suggesting that improvements 
in knowledge do not consistently lead to improved behavioural outcomes or medication 
adherence (Kim et al., 2015). Improvements in risk behaviour and testing, as well as 
compliance with scheduled appointments and medication, were grouped as behavioural 
outcomes of interest. Biological outcomes reported included pregnancy, blood alcohol levels, 
and change scores on validated depression and wellbeing scales. 
Of the twenty-two eligible studies, the vast majority (n=11) were sexual and reproductive 
health publications. A total of twelve studies were pooled in the meta-analysis, as they 
reported clearly on behavioural and biological outcomes required for answering research 
question 2. Similarly, the majority of these were on sexual and reproductive health (n=6) and 
mental health (n=5) topics.  
Table 3 shows the target conditions, intervention details, and key outcomes of all eligible 
studies selected for evidence synthesis (both narrative synthesis and meta-analysis, or 
statistical synthesis). The quality assessment based on the amended Cochrane tool is not 
reported in the evidence profile as allocation concealment was impossible due to the nature 
of the mHealth interventions. This did not detract from the scoping process as quality 
assessment is not mandatory, unlike for a systematic review. The majority of studies 
reported different methods of outcome aggregation and metrics, and thus these were not 
pooled.  
The table follows the classification of mental health, substance use and reproductive health 
for knowledge, behavioural and biological outcomes, shown in bold text. Three studies 
reporting on knowledge exclusively (namely Juzang et al., 2011; Brayboy et al., 2017; 
Montanaro et al., 2015) have not been elaborated on beyond this table. 
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Table 3 Characteristics of included studies (* denotes studies on knowledge only that are not further considered). 
Study author, 
date, and setting 
Age range and number of participants Target condition category /details of intervention and 
control groups 
Outcomes 
 
Brayboy* 
2017 
USA 
Mixed methods survey conducted on 
adolescent girls aged 12-17 years 
Reproductive health: GirlTalk smartphone application 
with culturally sensitive avatar to teach sexual health 
education to adolescent girls 
Modest improved knowledge on STI, anatomy, and 
relationships components only 
 
Bull et al 
2015 
USA 
Mixed methods study on adolescents 
between 16-25 years, mean age of 19 
years 
Reproductive health: Facebook page link to 
intervention website JustUs compared to an 
information-only popular culture website 
Statistically significant condom use in intervention 
group which was not sustained at 2-month follow-up, 
also reported on reduced risky sexual behaviour in 
terms of condom use. 
 
Juzang et al* 
2011 
USA  
Quasi-experimental trial in Black 
sexually active adolescents between 
16-20 years in Philadelphia, n=60, 
using their own phone. Intervention 
group mean age 19, control age 17 
years 
Reproductive health: Three texts per week for 12 
weeks on HIV risk behaviour and sexual health, 
were sent to the intervention group. The control group 
received placebo text messages on nutrition. 
Intervention group participants showed significantly 
greater HIV knowledge and a trend to monogamy at 3 
months. No difference in protected sex acts and 
delayed sexual debut at 3 months. 
 
Haug 
2017 
Switzerland 
Parallel group RCT among 1041 high-
school students, mean age of 16.9 
years. 494 students in control; 547 in 
intervention group. 
Alcohol use:MobileCoach Alcohol is an automated 
intervention of online feedback and individually 
tailored text messages addressing social norms, 
outcome expectations, motivation, self-efficacy, and 
planning processes. Only the alcohol-related 
integrated intervention outcomes were reviewed. 
Reduced risky single-occasion drinking (RSOD) 
prevalence in the intervention group by 5.9%; control 
RSOD prevalence increased by 2.6% over 3 months. 
No difference was seen in volume of alcohol consumed 
or estimated peak blood alcohol levels. 
 
Larimer 
2009 
USA/Sweden 
Observational study with 2236 
participants (852 in USA; 1384 in 
Sweden; 731 received PFI). 30% of 
USA sample and 52% Swedish 
sample classified as risky drinkers 
according to AUDIT-C. 
Alcohol use: To evaluate a web-based personalised 
feedback intervention (PFI) in high school seniors 17-
19 years old. Participants completed a survey 1 week 
after PFI, and at 6- and 12- months follow up. 6-month 
outcomes reported. No clear follow-up publication 
found for 12-month outcomes. 
Those in PFI group drank significantly less alcohol 
per occasion, had lower blood alcohol 
concentration (typical and peak) and drank on fewer 
occasions than those who did not receive the PFI. 
Effect sizes ranged from d = 0.12 to d = 0.22. No 
significant interaction seen from country setting in 
sensitivity analysis. 
 
Lim et al 
2012 
Australia 
Observational study with 994 
participants aged 16-29 years 
recruited at a music festival; 58% of 
sample16-19 years, with clear 
reporting of age disaggregates.  
Reproductive health: Protected sex, STI testing and 
knowledge, and change in health provider 
relationship measured at 6 and 12 months after 
intervention.The 12-month intervention included SMS 
(catchy sexually transmissible infections prevention 
slogans) and emails. 
Outcomes measured were health-seeking behaviour, 
condom use, risky sexual behaviour, STI knowledge.At 
12 months, intervention group STI knowledge was 
higher for both males and females; Women (but not 
men) in the intervention group were more likely to have 
had an STI test or discuss sexual health with a clinician. 
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Kobak et al 
2015 
USA 
Quasi-experimental study with 65 
adolescents aged 12-17 years. 
Refresher online CBT teaching for 
consulting therapists, who recruited 
participants with depression from their 
practice and assessed them 12 weeks 
after initiating treatment. 
Clinicians in the standard care arm 
also recruited patients initiating 
treatment for depression from their 
clinical practice, and treated them for 
12 weeks using usual care. 
Depression: Three components, each using 
technology; part 3 only is assessed, as an add-on to 
conventional treatment:(1) CBT online therapist 
training and (2) in-session tablet teaching CBT skills 
(both used by therapist);(3) SMS for between-session 
homework reminders and self-monitoring, directed at 
the adolescent. Two daily texts, with timing agreed 
upon beforehand: initial reminder text followed by one 
later to record results. Reports of all in- and outgoing 
texts sent to therapist before the next session. 
Individualized text messages were integrated into 
treatment as a between-session resource for 
participants. 
 
Effective in improving symptoms of 
depression in adolescents. User satisfaction with the 
technology was high for both therapists and patients. 
The therapeutic alliance was stronger in the cohort 
receiving the technology-enhanced intervention. Effect 
sizes comparing clinical outcomes between CBT and 
TAU were small. 
Measures of symptomatic improvement were greater on 
all outcome measures for the CBT arm, but none 
reached statistical significance. 
 
Manicavasagar 
et al 
2014 
Australia 
RCT feasibility in 235 adolescents 
aged 12-18 years.  
 
Depression:  Intervention is online delivery of an 
interactive positive psychology program, called 
BiteBack. Wellbeing and change in depression score 
was measured at baseline and 6 months after using 
BiteBack. 
Intervention participants had significantly improved 
depression and stress scores at 6 weeks post-
intervention. None of these significant differences were 
found in the control condition from pre-assessment to 
post-assessment. 
 
 
Ranney et al 
2016 
USA 
Quasi-experimental study with 16 
adolescents aged 13-17yrs with non-
clinical depression. 
Depression: Depression and violence self-report 
measured at baseline and 8 weeks. Intervention was 
cognitive behavioural therapy tool for depression 
prevention. 
Improved depression and wellbeing scores after 
initial and 8 week follow-up, no change to violence 
self-report 
 
Montanaro et al*  
2015 
USA 
Ages 11-14 years, 333 participants in 
RCT.  166 in intervention, 167 in 
control.   Analysed only 166 
participants in intervention group.  
Substances other than tobacco: Videogame 
PlayForward developed for risk reduction in substance 
use.  Participants played the intervention game or a 
set of attention- and time-matched control games for a 
maximum of 16 hours over 6 weeks. 
Mastery of the game rather than time spent using 
intervention was significantly correlated with improved 
substance knowledge at 3 and 6 months. Later 
publication (Fiellin et al, 2017) examined full study 
sample for sexual health behaviour after 1 year. 
 
Rokicki et al 
2017 
Ghana, Africa 
Cluster–randomized controlled trial 
among 756 female students aged 14 
to 24 years in Accra, Ghana, in 2014. 
Reproductive health: Unidirectional and bidirectional 
text messaging-based interventions for sexual health. 
The unidirectional intervention sent participants text 
messages with reproductive health information. The 
interactive intervention engaged adolescents in text 
messaging reproductive health quizzes. Control group 
participants received weekly placebo messages on 
malaria. 
The unidirectional and the interactive programs 
significantly lowered the odds of self-reported 
pregnancy by 86% in the adjusted models (odds ratio 
[OR] = 0.14; 95% CI = 0.03, 0.71) and 85% (OR = 0.15; 
95% CI = 0.03, 0.86), respectively. There were 
significant improvements in knowledge at 3 months 
that were sustained after 15 months for both uni- and 
bi-directional programmes. The bi-directional 
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programme was significantly more effective than the 
one-way programme. 
Scull et al 
2017 
USA 
A cluster randomized controlled trial 
(RCT) design among 35 adolescents 
aged 18-19 years.  
Reproductive health: Use of intervention MediaAware. 
Knowledge of STI's and change in sexual risk 
behaviour measured at intervention-end. 
Compared to the control group, both men and women in 
the intervention group reported fewer instances of oral, 
vaginal, or anal sex with someone who has not been 
tested for STIs or whose STI status is unknown. At 
post-test, the intervention group participants scored 
significantly higher on knowledge scores than the 
control group. 
 
Tahaney et al 
2017 
USA 
College undergraduate students, with 
high-risk drinking behaviour as 
defined by authors, were recruited 
online (N = 113) and randomized to 
Assessment only (AO), web 
intervention (WI) or WI plus text 
messaging (WI plus TXT).  
Alcohol use: Commercially-available web-based 
intervention (eCHECKUP TO GO-alcohol) that 
provides individualized feedback on drinking behavior, 
such as drinking norms, costs and consequences of 
use, alternative activities, and change strategies. WI + 
TXT condition received one text per day over the 
month between baseline and follow-up, delivered 
before anticipated weekend drinking episodes. 
WI + TXT condition showed significantly less weekend 
drinking than those in the AO and WI group. The WI + 
TXT and WI only groups showed comparable, 
significantly fewer heavy drinking episodes compared 
to AO. No differences were observed on alcohol-related 
problems. No group sizes reported and only adjusted 
effect size. Plot digitizer used to impute values into 
RevMan. 
 
Weitzel et al 
2007 
USA 
Forty college students randomised to 
either intervention or control. 
Alcohol use: Feasibility and short-term outcomes of 
tailored text messaging intervention. Intervention 
group additionally received text messages tailored to 
reported behaviour, self-efficacy and outcomes 
expected regarding alcohol-related consequences. 
 
Intervention group participants reported significantly 
less binge drinking(p=0.02) than control on-study. 
Little detail on the text message frequency. Mean 
duration of receiving messages was only 14 days. 
Unable to contact author for raw data. 
 
Ybarra et al 
2017 
USA 
RCT on male 14 to 18 year- old gay 
or bisexual participants recruited via 
Facebook. 
Reproductive health: Interactive website Guy2Guy 
(G2G) used together with text messaging for 5 weeks. 
Between 5-10 text messages delivered daily, with a 1-
week booster was delivered after 6 weeks. Control 
group received an attention-matched “healthy lifestyle” 
(e.g. self- esteem) programme. Protected sex acts, 
abstinence and HIV testing measured at 3 months 
after intervention-end. 
90 days post-intervention participants were significantly 
more likely to report getting an HIV test (adjusted odds 
ratio = 3.42, P = .001) and CSAs were significantly 
lower for those in the intervention versus control at 
intervention end (incident rate ratio = 0.39, P = 0.04). 
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Narring et al 
2013 
Switzerland 
Participants were 12-24 years, with a 
mean age of 17 years in the setting of 
a primary care youth clinic. 462 
adolescents were randomised to 
mHealth intervention, 529 in control 
group.  
 
Reproductive and Mental health:‘Easy Smart Care’, a 
software product developed by EasyMed Services Inc. 
Phone numbers were entered into a secure web 
platform which automatically sent generic text-
message reminders between 08:00 and 11:00 the day 
before the planned appointment, including on 
Sundays. The text, written in French, stated: ‘You 
have an appointment on... (date) at ... (time) with Dr ... 
(name) Please answer NO if you do not intend to 
come’. Patients in the control group received no 
reminder. 
 
Assessed clinic attendance at gynaecology and mental 
health youth outpatient clinic. The outcome was the 
proportion of unexplained missed appointments, without 
prior notification. The study is included in pooled 
analysis to show the mental health clinic attendance 
results only. 
The proportion of missed appointments was 16.4% 
(95% CI 13.1% to 19.8%) in the text-message group (N 
462) and 20.0% (95% CI 16.6% to 23.4%) in the control 
group (N 529), showing no significant effect of the 
intervention (p=0.346). 
Branson et al 
2013 
USA 
Adolescents between 13-17 years of 
age, drawn from a convenience 
sample of an outpatient mental health 
clinic. Quasi-experimental study 
design with an historical control. 
Mental health:The control treatment as usual group 
(TAU) did not receive any reminders, while the 
intervention text messaging (TM) group received 
additional reminders for each therapy session over a 
3-month period. The intervention was static, with no 
option of replying to the reminder message. 
 
Assessed Mental Health clinic attendance. Adolescents 
receiving TM reminders had significantly higher rates of 
clinic attendance (65%) than a historical control group 
(49%) (p = 0.05). The attendance rate for the TM group 
(Mean 64.9%, SD  22.3%) was significantly higher than 
control group (Mean 49.3%, SD 24.5%), F (1, 46) = 
5.33, p 0 .026, d = 0.67.  
Trent et al 
2015 
USA 
Observational study among 100 
adolescents and youth (ages16-25) 
with mean age of 19yrs.  
Reproductive health: Follow-up for three 3-monthly 
cycles of Depo-Provera injectable contraceptive. 
Intervention (n=50) received daily bidirectional SMS 
reminders starting 72 hours before scheduled 
appointment. SOC (n=50) was automated reminder 
message to home telephone androutine call by nurse 
after missed appointment to return in on-time  
Assessed the proportion of on-time injectable 
contraceptive administration (Depo Provera). Non-
statistically significant on-time appointments for second 
and third cycle in Intervention group. No overall 
difference to on-time administration. Intervention may 
have potentially greater impact in settings without nurse 
call after missed appointments. 
Cornelius et al 
2013 
USA 
A single- group pre-post observational 
study with assessment of outcomes at 
three timepoints among 40 Black 
adolescents aged 13-18 years. 
Reproductive health and substance use: BART 
(Becoming a Responsible Teen) is a 7-week 
community-based HIV prevention programme to 
develop safer sex behaviour. This project examined 
the add-on effect of bi-directional booster messages 
for 3 months after completion of the BART course. 
Daily booster messages (SMS, video, pictures) for 
3months, sent at 3pm daily and participants were able 
to text their facilitators with related questions.  
 
Participants in the intervention group showed no 
significant improvement in HIV knowledge, reduced 
risky sex acts and reduced risk drug use compared 
to control at 3 months. Age was a primary factor in 
change, with a trend to benefit among older participants 
(16–18 years of age). 
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Matheson et al 
2014 
USA 
Adolescents between 11-22 years of 
age, with mean age of 19 from an 
urban paediatric clinic setting.  
37 participants were randomised to 
intervention, 232 to control. 
Reproductive health: Participants received text 
message reminders for the second and third dose of 
HPV vaccine over an 8-month study period. Each 
participant received three text message reminders per 
dose: one message 7 days prior to each HPV vaccine 
due date, one on the vaccine due date, and one 7 
days after the due date. 
Assessed HPV completion and HPV doses on-
timefor dose 2 and 3. 14% of participants in 
intervention group completed the vaccine series on-
time 3% of control completed the vaccine series on-
time  
Fiellin et al 
2017 
USA 
Randomised trial with 11-14 year 
olds, with mean age 12.9 years. 258 
evaluable participants at 12 months; 
129 in intervention, 129 in control 
Reproductive health: Interactive videogame where the 
player avatar “travels” through life, facing challenges 
and making decisions in sexual risk and substance 
risk, unsafe driving scenarios. Control group played 
time and attention-matched games for the same 6-
week period.  
Outcomes assessed 1 year after intervention: No 
difference was found in delay of sexual debut.Boys 
and younger intervention participants showed improved 
sexual health attitudes overall compared to the control 
group at 12 months. This effect was not seen in girls, or 
older adolescents. 
Jeffries et al 
2017 
USA 
Poster presentation of a randomised 
pilot trial among 146 HIV-positive 15-
24 year-olds.  
Reproductive health, alcohol use: Intervention group 
received 12 texts per week. Control received standard 
of care. 
Incompletely reported on outcomes of HIV viral load 
and risky single-occasion drinking. Viral load for 
intervention group was statistically significantly lower 
than control at 3 and 6 months follow-up. Those who 
were non-adherent or new to ART benefited most with 
lower viral loads and substance use knowledge.  
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Five studies addressed mental health conditions of depression, wellbeing and violence 
(Branson et al., 2013; Narring et al., 2013; Manicavasagar et al., 2014; Kobak et al., 2015 
and Ranney et al., 2016).No studies reported on suicide, and only one study reflected 
violence by participant self-report.  
Infectious disease categories were non-SRH (e.g. TB, influenza) and SRH. SRH was further 
sub-categorised into  
i) curable STI’s (chlamydia, gonorrhoea, syphilis, etc.)  
ii) non-curable STI’s (HIV) and  
iii) vaccine-preventable STI’s (HPV) 
STI studies reported on condom use, risky sex behaviour and STI knowledge. One study 
reported on HPV immunisation adherence as both completed and on-time vaccination 
(Matheson et al., 2014). 
No studies were found on adolescent non-sexual and reproductive health infectious disease, 
specifically TB and vaccine-preventable influenza. One conference poster (Jeffries et al., 
2017) incompletely reported on HIV viral load and binge-drinking in adolescents with HIV, 
and was thus not included in the meta-analysis. 
Biological outcome reporting was rare. Only one study reported on the incidence of 
pregnancy (Rokicki et al., 2017). A single poster presentation reported on biological HIV-
related outcomes of viral load measurement (Jeffries et al., 2017).  
4.3 Country settings and participant ages 
Figure 3 depicts where adolescent mHealth research occurs. Most studies were conducted 
in advanced economy settings of the global North, specifically in the US (n=16) and Europe 
(n=3). Only three studies were conducted in global South settings, Africa and Australasia. 
The study that took place in Ghana, Africa, was conducted on14-19 year old adolescent girls 
for sexual health outcomes (Rokicki et al., 2017). The other two studies were on sexual and 
mental health outcomes in Australia (Lim et al., 2012; Manicavasagar et al., 2017). 
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Figure 3 Country distribution of included studies 
Adolescent study population ages were skewed towards older (ages 15-19), rather than 
younger ages. Twenty-one of the included studies reported on adolescents over the age of 
sixteen years; six of these also reported on those younger than 16 years. Two studies 
reported exclusively on adolescents under 16 years, which was a videogame developed for 
HIV and substance use risk reduction targeting 11-14 year-olds (Fiellin et al., 2017 and 
Montanaro et al., 2015). Abstinence, or delay of sexual debut in younger adolescents under 
the age of 15 years, was examined in only the Fiellin study (2017) where no difference was 
found in delay of sexual debut compared to control one year post-videogame intervention. 
Boys and younger intervention participants showed improved sexual health attitudes overall 
compared to the control group at 12 months. This effect was not seen in girls or older 
adolescents. 
As regards the research setting, most studies were conducted among post-high school 
students. Whereas two studies were done in a high-school setting before transitioning to 
college (Juzang et al., 2011; Rokicki et al., 2017). Reaching adolescents before they 
transition into potential college settings of increased risk, may minimise the effects of binge-
drinking and substance use on the developing brain, while providing the opportunity for early 
diagnosis of mental disorders. 
4.4 Sexual and reproductive health studies 
Overall, sexual health studies (n=11) reported predominantly behavioural outcomes such as 
STI testing, condom and contraception adherence and addressed multiple elements 
simultaneously. Six studies were eligible for pooling (Scull et al., 2017; Lim et al., 2012; 
Rokicki et al., 2017; Trent et al., 2015; Bull et al., 2015; Ybarra et al., 2017). 
73%
14%
9.00%
4.00% Studies
USA	n=16Europe/UK	n=3Australia	n=2Africa	n=1
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Three studies (Cornelius et al., 2013; Lim et al., 2012 and Rokicki et al., 2017) reported 
knowledge as well as behavioural or biological outcomes. One study addressed HPV 
vaccine completion (Matheson et al., 2014); another study addressed outpatient clinic 
attendance as a measure of adherence (Narring et al., 2013). 
Condom use was reported as either protected or unprotected (condomless) sex acts. Four 
studies with 648 participants reported condomless sex acts. Condom use was reported by 
one large study with 1092 participants.  
Figure 4 shows the three studies reporting an odds ratio (Rokicki et al., 2017; Lim et al., 
2012 and Ybarra et al., 2017). Moderate heterogeneity (I-squared value = 64%) was found 
between studies. OR is 1.68 across the studies, and statistically significant with CI=1.12-
2.51. Those studies ‘not estimable’ in the forest plot reported no raw data, only adjusted 
event values or ratios.STI testing was reported by two studies (Ybarra et al., 2017; Lim et al., 
2012). Lim (2012) is examined under a subsequent heading (4.7) of gender subgroups. 
Figure 4 mHealth evidence: Sexual and reproductive health studies 
Ybarra examined condom use and STI test prevalence in sexually active male 14-18 year 
old participants at 3 months after intervention-end. The intervention was an HIV education 
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and prevention programme delivered as 5-10 daily SMS, for 5 weeks. They reported both 
events and adjusted values, with raw data depicted in the forest plot (Figure 3). The adjusted 
OR for HIV test at three months post-intervention was 3.42 (CI= 1.65-7.09). Sexually active 
participants in the intervention arm were 3.42 times more likely than control participants to 
have an HIV test at 3 months. The wide confidence interval illustrates its imprecision: the 
true effect on HIV testing may be as low as 1.65 times, or as much as 7 times, more likely. 
Our analysis of raw data yielded a similar OR of 3.43 (CI=1.71-6.89). 
The adjusted incident rate ratio (IRR) for condom-protected sex acts was 0.95 (CI=0.45-
2.02). The reasons for reporting an adjusted IRR due to skew in data are not well-reported. 
Our analysis of the raw data shown in Figure 4 yielded an OR of 0.68 (CI=0.31-1.49). This 
describes the intervention group as being 32% less likely than control to use a condom, with 
an imprecise, non-statistically significant confidence interval. 
The third study, Rokicki et al (2017) examined secondary outcomes of pregnancy self-report 
after one year, and unprotected sex. The analysis was done among a group of 14-24 year 
old sexually active female students, and by SMS intervention subgroup. Unidirectional SMS 
messages delivered to participants were compared with bidirectional communication 
(Rokicki et al., 2017). The control group received information on malaria rather than SRH. 
Both uni- and bidirectional interventions were significantly effective in lowering likelihood of 
pregnancy with adjusted OR’s of 0.14 and 0.15, respectively. The study further reports 
significant improvements in knowledge durability at 15 months with the bi-directional 
programme compared to the one-way programme. Both interventions were reported as 
superior to the control (not shown). 
Multiple outcomes (knowledge, condom use and pregnancy prevention) could not be pooled 
due to inconsistent effect sizes reported. By calculating the log OR and 95% confidence 
interval from the SMD and RR it was possible to estimate the overall effect of mHealth 
across more studies, by outcome reported, as depicted in Figure 5. The additional 
components gleaned here were information on pregnancy prevention, STI testing and 
condom use. Half as many female participants in the intervention group than control self-
reported pregnancy in one year (OR of 0.47). This corresponded to 8 per 100 pregnant 
intervention participants, compared to 16 per 100 in the control, with an imprecise 
confidence interval of 0.17 to 1.26 (the true effect lies between of 3 to 18 per 100 
pregnancies). Effect on STI testing was favourable for mHealth over control, with an OR of 
0.45 and a precise, statistically significant CI (0.26-0.78). This would suggest a 55% 
increased likelihood of STI testing with mHealth. However, this result should be taken 
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conservatively, as the moderate heterogeneity of 61% signals that this effect may vary in 
different settings. 
The effect of mHealth on condom use showed only 16% increased likelihood of use 
(OR=0.84); this effect was seen as statistically non-significant (CI=0.56-1.27), again with 
moderate heterogeneity of 64%. Even though the element of knowledge was initially 
included in this pooling, the overall effect of mHealth on these multiple aspects of SRH still 
remains favourable. 
 
Figure 5 mHealth evidence: multiple sexual and reproductive health outcomes 
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4.5 Substances other than tobacco 
Six studies covered alcohol and substance use exclusively (Montanaro et al., 2015; Haug, 
2017; Jeffries et al., 2017; Weitzel et al., 2007; Larimer et al., 2009; Tahaney et al., 2017), 
while Cornelius (2013) reported on sexual health outcomes as well. Four studies focused on 
risky single occasion drinking, with individual studies reporting biological outcomes of blood 
alcohol levels post-intervention (Jeffries et al., 2017) and knowledge (Montanaro et al., 
2015). 
Three studies addressed intervention impact on risky drinking behaviour, defined as “binge” 
or risky single-occasion drinking by the study authors.  
Most studies (n=6) were ineligible for pooling due to incomplete reporting. An isolated study 
with clear reporting was an RCT conducted by Haug on 477 participants in Switzerland 
(Figure 6). Subgroups were analysed according to risk, defined as the number of drinks per 
episode. Medium risk was defined by the authors as 4-5 drinks, and high risk as 6 or more 
drinks per episode. The overall intervention effect favoured mHealth, with an OR=0.68, 
defined as a 32% reduced likelihood of RSOD. The effect of the intervention was even 
stronger in the group of high risk drinkers, who showed a 72% reduced likelihood of risky 
single-occasion drinking post-test (OR=0.28). This was both statistically significant and 
precise. It can be seen that the overall effect was diluted by efficacy in the medium risk 
subgroup, which unfortunately had more than twice the weighting (due to a larger sample).  
Cornelius (2013), not shown, reported minimal intervention effect on risky drug use with a 
mean difference (MD) of 0.62 lower compared to pre-intervention. This was a pilot repeat 
measures RCT with a small sample of 71 participants, conducted within a study setting 
geared at examining primary sexual health outcomes.  
 
Figure 6 mHealth efficacy for risky drinking behaviour (Haug et al., 2017) 
4.6 Mental Health conditions 
Depression scores reported showed a change in 407 participants across 5 studies, reported 
as mean difference of 4.01 lower in the mHealth group on validated depression scales 
(higher scores reflect worse outcomes) with an imprecise CI showing the true effect to lie 
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anywhere between 8.83 points lower to 0.82 points higher.  This wide margin in precision 
may be due to the different depression scales used in studies, as well as the clinical 
spectrum of subclinical, to overtly depressed adolescents. This is similarly reflected in a high 
heterogeneity score of 84%, reflecting the need for caution with interpretation.  
The wellbeing score was examined in three studies among 174 participants with a mean 
difference of 2.17 points higher with mHealth (higher scores reflect improved outcomes). 
Improved wellbeing ranked higher on the validated scales used in the studies, with an 
imprecise true effect (CI= -2.86 to 7.2); between 2.86 points lower and 7.2 points higher on 
the scale.  
4.7 Effect of gender 
The study by Lim was the only study reporting outcomes by subgroup of gender (Figure 7). 
Outcomes reported were proportion of protected sex acts, improved knowledge score and 
STI testing at 6 months, as well as the likelihood of consulting a health care provider at one 
year post-intervention. Timepoints reported were one year and 6 months post-intervention. 
Behavioural outcomes of both STI testing as well as consulting a health care worker were 
better for females than for males, with similar durability of effect persisting up to twelve 
months. Although females initially scored better for STI knowledge, knowledge retention at 
twelve months was better for males than for females. 
 
 
Footnote: 6 and 7) STI test 6 months;    8 and 11) knowledge score 12 months;      9) HCW affiliation 12 months 
Figure 7 Gender subgroups (Lim et al., 2012) 
However, the improved 12–month knowledge scores in males did not translate into improved 
protected sex practice in the male group, only in females. This is consistent with published 
research which shows that although interventions may improve knowledge, this alone does 
not consistently lead to positive health behaviour, especially with longterm conditions such 
as HIV and mental health where self-motivation and social support are vital (Kim et al., 
2015). Furthermore, effects of improved knowledge may have contrary effects, such as 
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reduced condom use. Previous literature has accounted for this reduced condom use, by 
intervention effect of increased monogamy and less risky partners overall. Message framing, 
such as content focusing on ‘pregnancy prevention’, rather than ‘barrier contraception’ may 
also have unintentional effects such as improved oral contraceptive adherence, with 
reduction in barrier methods (Rokicki et al., 2017). 
Males were also less likely than females to consult health care workers for sexual health 
concerns. Notably, females were almost twice as likely as males to have spoken to their 
health care worker about sexual health concerns, or have had an STI test, one year post-
intervention. The reported OR of 1.85 was statistically significant and did not cross the line of 
one (null effect, where control and intervention are equivalent). Furthermore, when analysed 
in the fixed effects model which assumes that all conditions within the two gender subgroups 
are the same, the significance increased further to an OR of 1.97. This effect favouring 
mHealth over standard care remained statistically significant, as confidence intervals in both 
models did not cross the line of one. 
4.8 Effect of follow-up duration 
The longest duration of follow-up across all the studies was 36 months (Rokicki et al., 2017). 
As its overall findings were reported as RR, it could unfortunately not be pooled with the 
other studies on reproductive health outcomes (all reported OR), so is shown in the lower 
half of Figure 8. The risk ratio shows an almost 50% reduction in sexual risk behaviour using 
the intervention. However, this effect is not statistically significant or precise, as the 
confidence interval is broad (CI 0.21 - 1.21) and crosses the line of 1.  
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Figure 8 Efficacy for longer follow-up durations (Lim et al., 2012; Rokicki et al., 2017) 
4.9 Summary 
We found a preponderance of sexual health publications; fewer for mental health; even 
fewer for drinking and substance use; and none for infectious diseases TB and vaccine-
preventable influenza.  
Our results indicate that most outcomes reported were behavioural, and self-reported. Time 
period of follow-up post-intervention was variable, although only two studies reported on 
participants for more than 12 months, despite the chronic nature of many interventions. This 
is of some concern as longer periods of observation are preferable when establishing 
efficacy of interventions. This may also partly explain some of the variable results in the 
sexual health studies regarding condom use, as follow-up periods varied widely in these 
studies (from two weeks to 1 year). 
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Behavioural outcomes included abstinence, condom use, STI testing, risky alcohol and drug 
use, compliance taking medication and clinic attendance.The vast majority of studies were 
related to sexual and reproductive health outcomes, assessed commonly as combinations of 
knowledge improvement and biological or behavioural outcomes. The biological outcomes 
addressed included pregnancy, depression scores and wellbeing scores. Risk of pregnancy 
was reliably halved using mHealth in an RCT of 172 participants (OR 0.47).There was a 
clear improvement in health provider affiliation, especially in females for sexual health 
concerns. Clinic attendance showed marginal improvement in three studies among 991 
participants. The two studies among 742 participants assessing STI testing showed only a 
small to moderate effect. 
The mHealth evidence for improved depression scores was moderate with a change score 
improved by mean difference (MD) of 4 points, consistent across the studies. Wellbeing 
showed smaller, consistent improvement.  
Risk behaviours encompassed risky sex, risky drug use and risky alcohol use. Risky drug 
use and sex practice showed small and inconsistent improvements with mHealth. Risky 
drinking showed considerable improvement with mHealth (32% reduction), and was 
examined in a larger sample of 477 participants. In the initial search, only Montanaro et al. 
(2015) and Fiellin et al. (2017) reported on the beneficial effects of videogames on male 
sexual health knowledge. Improved alcohol risk behaviour and knowledge was related to 
mastery of the game, rather than time spent playing it. The intervention had no effect in girl 
and older adolescents, only younger, male participants. Given that both studies showed 
beneficial effects, this is an area of mHealth that should be explored further. Fiellin et al. and 
Montanaro et al. were also the only studies targeted at younger adolescents between 11-14 
years.  
Despite estimations that the largest numbers of adolescents reside in Asia (ITU, 2017), we 
found no mHealth publications from this region, although there was no language limitation 
placed on our search. There was no representation of teens in rural or homeless settings, 
and only one from a school setting with an add-on intervention. Similarly, there was no 
representation of acute conditions such as unintended injury, violence or suicide. 
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Chapter 5: Discussion and Conclusion 
The study set out to examine the evidence for effective adolescent mHealth interventions for 
knowledge transfer to LMIC’s to implement adolescent immunisation. An initial objective was 
to map the mHealth evidence for target conditions that contributed significant morbidity to 
the adolescent global disease burden. This step is referred to as “charting the evidence” in 
scoping methodology, and requires sufficient well-reported literature (Colquhoun, 2014). 
5.1 Factors that affect intervention efficacy 
More than seventy percent of 15-24 year-olds globally are reported to be online for at least 
an hour daily (International Telecommunication Union, 2017). However, the evidence 
highlights the skew of mHealth research to high-income nations where adolescents are more 
likely to own smartphones capable of accessing the internet, or may access the internet at 
home or places of learning. We found three adolescent studies from Africa and Australia, in 
stark contrast to an adult mHealth systematic review reporting fewer publications from the 
global North, and an upswing in those from Australia and Africa in the last decade (Fiordelli, 
Diviani & Schulz, 2013). To our knowledge, no similar systematic review has looked at the 
global distribution and frequency of mHealth publications among the adolescent age group 
exclusively, despite their high internet usage. 
Our findings also highlight the skew in evidence towards chronic conditions and sexual 
health topics. The vast majority of studies were related to sexual and reproductive health 
outcomes, assessed commonly as combinations of knowledge improvement and biological 
or behavioural outcomes. This finding is consistent with the Fiordelli et al. (2013) review 
reporting a predominance of chronic, rather than acute, conditions in mHealth literature 
between 2002 and 2012. Fiordelli recommended then that mHealth for acute conditions 
should be explored further, due to its unique capability for continuous communication. The 
Global Burden study has shown that violence and road traffic accidents cause 20% of all 
adolescent deaths (Mokdad, 2016). Further, road traffic injuries constitute the highest cause 
of death in younger and older male adolescents; whereas the leading cause of death 
changes from respiratory causes, to maternal causes in older female adolescents (WHO, 
2017). The mHealth capacity for continuous or bidirectional communication may be useful in 
health promotion, as well as in acute emergencies. However, we found that all of the 
evidence addressed non-acute conditions. No studies were found on suicide or road traffic 
accidents. 
The gap in the evidence of most concern, given the nature of our scoping project, was the 
lack of infectious disease publications on adolescent TB. Further, the absence of adolescent 
mHealth research for infectious disease examining biological and behavioural outcomes 
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overall is surprising, given advances in drug discovery, and recent outbreaks such as Ebola 
and Zika virus. Such studies may however have been published since November 2017, or 
may be in the publication pipeline. 
In terms of the study setting, recent reviews report promising adolescent outcomes in school 
settings for both high income countries and LMIC’s, and for non-mHealth (Barry, 2016) as 
well as mHealth interventions (Champion, 2017). The beneficial effect of mHealth as seen in 
school settings may be by facilitated by allowing confidential interaction for personally 
relevant topics, thereby bypassing peer pressure and perceived stigma. Both of the studies 
we found with mHealth add-ons to a high-school-based curriculum reported positive 
knowledge and health outcomes (Juzang et al., 2011; Rokicki et al., 2017). Hence we 
concur with multiple researchers who suggest that mHealth as an add-on holds promise. 
However, mHealth add-ons to school-based programmes may miss those not in mainstream 
schools such those living on the street, in correctional facilities and in chronic rehabilitation 
programmes. More studies examining alcohol and substance use were found conducted 
among college, rather than high-school, students. The privilege of continuing to tertiary 
education, or remaining in mainstream secondary education, is tenuous in many rural 
settings, emerging economies and areas of conflict. The question of how to target 
adolescents before transition to further education, and outside of traditional school settings, 
could potentially be an area for important future work. 
Most of the studies found used either bidirectional or static text messaging as a follow-up to 
another standard of care practice. The appeal of smartphones is that they allow 
personalisation - apps and games may be customised to user preference by a myriad of 
background settings, sounds and culturally-sensitive avatars for example. The app can 
usually be accessed on another device. Most users do not keep the same mobile device for 
more than two years, and phones may be lost, stolen or break down. Using a text-based 
intervention exclusively with a single mobile telephone number, may therefore be less useful 
in settings where users change numbers (or SIM cards) frequently. Engagement platforms 
like WhatsApp may therefore be more relevant in country settings where users share or 
change SIM cards frequently, yet retain a single profile for access.  
As wireless technologies have changed over time, so have social media preferences 
between younger and older adolescents, as well as boys and girls. Two recent surveys by 
Pew research organization in the US showed that adolescents spent more time on social 
media than sending text messages (Lenhart, 2015; Anderson, 2018). Girls preferred 
visually-orientated social media platforms such as Instagram and Snapchat, while boys of all 
ethnicities were more likely to play videogames (Lenhart, 2015). Apps and videogames may 
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therefore hold more potential for targeting younger adolescents than bidirectional texting, for 
example. Yet our findings do not reflect this change in user preference, as the vast majority 
of evidence was for text messaging as mHealth modality, despite reasonable infrastructure 
supporting internet connectivity. Low and middle-income country infrastructure and 
ownership of older mobile phones among adolescents may limit full exploitation of newer 
platforms such as WhatsApp. Thus, SMS might still be preferable for countries where 
connectivity may be poor. In countries such as South Africa, Nigeria and Kenya with good 
mobile connectivity, there may be a role for exploring the newer platforms in adolescent 
studies. However, the data costs in these countries remain relatively high compared to 
Europe and North America (ITU, 2017).  
5.2 What does this mean for implementation of adolescent global health 
interventions? 
This study found incomplete reporting of primary studies, which would impact on knowledge 
transfer at multiple steps. Most studies reported the technology platform, health information 
system context, user feedback and intervention content aspects increasingly better over 
time. Whereas facets such as contextual adaptability and replicability, limitations to scaling 
the intervention, and how individual participants accessed the intervention, remained under-
reported. We would argue that these latter aspects are as vital for successful knowledge 
transfer as for understanding reasons for inconsistent outcomes of infectious disease 
adherence mHealth interventions. Such information is needed before subsequent systematic 
reviews are able to map statistical efficacy trends for interventions. An example of the need 
for detailed reporting, is the earlier reference to the Lester et al. (2010) study that showed 
promising outcomes for adult ART medication adherence using mHealth in Kenya. This 
success was replicated by King et al (2015), in a Canadian setting. Yet Mbuagbaw et al 
(2011) and Shet et al (2014) failed to show similar success for adult ART adherence in 
Cameroon and India, respectively. It was only when more time had elapsed, that a 
subsequent systematic review clearly showed efficacy was dependent on the bidirectional 
nature, and frequency of messages (Anglada-Martinez, 2015). We would therefore 
encourage all mHealth researchers to report findings in accordance with both the study-
specific guidelines (such as STROBE for observational studies; CONSORT for RCT’s etc.) 
and the CONSORT-EHEALTH checklist (Eysenbach et al., 2011). 
The small number of studies on younger adolescents under the age of 16 raises the 
question of whether recruitment is reduced when parental consent is required. Some ethics 
boards, such as those in the UK and South Africa, require parental consent (as well as 
adolescent assent) for research on those under the age of 18 years; this exists even for 
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hard-to-reach minority groups such as young men-who-have-sex-with-men (MSM). The 
process to waive the widely-accepted ethics requirement of parental consent is laborious, 
even when these adolescents legally are able to make independent decisions on 
contraception and obstetric procedures. This begs further investigation and novel ways of 
approaching regulatory requirements in younger adolescents. In addition, many social 
network platforms (such as Facebook) have banned any sexual health advertising content to 
under-18-year-olds due to privacy laws, including recruitment advertisements from validated 
sexual health research organisations. The low numbers of adolescents under the age of 
sixteen years in these studies may be therefore be in part due to missed opportunities in 
recruitment due to regulatory and legislative hurdles, rather than lack of research focus. 
Despite making up a third of the population in many countries, there is a significant risk that 
the great advances in maternal and child health gained through the MDG’s stand to be lost 
by lack of global investment in adolescent health (WHO, 2014c). The latest WHO 
publication, Global Accelerated Action for the Health of Adolescents (WHO, 2017) reflects 
better data reporting by country programmes, and an understanding of the intersectoral 
collaboration required for health and social policies for adolescents. This is vital as most 
adolescent social determinants of health such as education and employment, are not within 
the ambit of the traditional health system. It is of concern that the only current adolescent 
SDG indicator is pregnancy rate, another sexual health statistic.  
5.3 Limitations and recommendations 
In this review, some methods of a systematic review were used; however, it remains a 
scoping review. Its purpose is to inform gaps in the knowledge base and findings should be 
interpreted bearing in mind that many of the studies were pilots, underpowered for efficacy 
determination.  
Some pilot studies were informative for testing proof of concept; however, inconsistency of 
authors across successive publications made it relatively difficult to trace the follow-up RCT 
for example. We found that feasibility studies and pilot studies were not clearly delineated by 
study title. This lack of clarity became important when keywords and titles were scanned in 
the initial steps, as pilots and feasibility studies serve different functions in preliminary 
research, whereas we were interested in health outcomes. In this review, only two studies 
used reporting guidelines from the CONSORT E-HEALTH checklist for pilot studies, which 
delineates the initial feasibility and follow-up pilot phases (Eysenbach et al., 2011). 
Arksey and O’Malley (2005) invited researchers using the scoping process to publish, 
comment and build on their initial discussion to advance the methodology. Multiple studies 
since then have noted that the process took more than a year, and was not necessarily a 
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“rapid mapping” of literature. This was noted to be the case even when quality assessment 
was not done (Levac, 2010; Daudt, 2013). We would therefore agree that our scoping 
process was more in line with the Daudt definition, which entails mapping the literature while 
“identifying key concepts, research gaps and types and sources of evidence”. However, 
regardless of definition used, there is a clear need for better reporting guidelines for 
mHealth, which would benefit both the scoping and systematic review process, both for 
broadly mapping the literature, and for describing the best available published evidence. 
As regards the reporting of scoping reviews generally, we concur with multiple researchers 
on the value of supplementing Arksey and O’Malley’s initial framework with subsequent 
publications that build on the methodology (Levac et al, 2010; Daudt, 2013; Peters et al., 
2015a). Several Joanna Briggs Institute suggestions such as the use of multiple structured 
searches, and a multi-disciplinary team approach, would prove useful to follow-up work to 
this review (Peters et al., 2015b). Further strengths of the Joanna Briggs Institute framework 
include an approach to multiple research sources (quantitative and qualitative), as well as 
complex interventions in their model of evidence transfer to various economies and 
healthcare settings (Peters et al., 2015b).  
Furthermore, as in most research, larger, commercial studies were well-funded with bigger 
numbers, but few had transparent raw data placed into the public space. Some authors were 
unable or unwilling to provide adolescent data when contacted for age-related information. 
This occurred either due to the data not being captured, where adolescents fell within a 
much larger age cohort; or alternatively, that the use of platforms such as Google analytics 
kept age-related patient data confidential, an unintended effect. Only six eligible studies 
provided complete supplementary data by appendix or online publication. This may lead to 
duplication of efforts, where existing data is not easily verified or built upon. A 
recommendation would be for researchers to report their findings clearly upfront. Specific 
details on the phase of study design should be captured in the title and the abstract should 
refer to preliminary work, relevant keywords, and the age disaggregation reported. An 
example of such a specific reporting checklist for abstracts is the PRISMA abstract checklist 
shown in Appendix 5 (PRISMA, 2009). 
A unique strength of the scoping process remains its iterative nature. We would therefore 
recommend that more scoping reviews be published, so that others may learn from the 
process. Arksey and O’Malley intended for the process to be iterative, and formative, with 
researchers sharing insights and pitfalls experienced during the process, so as to grow the 
methodology.  
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In this review, only two studies used mHealth reporting guidelines. The only journal we know 
of that mandates eHealth and mHealth reporting guideline use for RCT’s, is the Journal of 
Medical and Internet Research. Multiple authors have commented on the specific challenges 
posed by wireless interventions, which require additional reporting guidance to the widely-
adopted study-design specific checklists (Eysenbach, 2002; Moher et al., 2010).The 
CONSORT-EHEALTH checklist was intended for use in conjunction with the CONSORT 
statement for reporting RCTS’s of mHealth interventions. It was developed to enable 
replication and peer-learning from mHealth publications (Eysenbach et al., 2011). 
Unfortunately, as it was merely an extension document, the guideline was rarely used. The 
WHO therefore developed an mHealth working group (mTERG), and advocates use of their 
mERA checklist for publications (Agarwal et al., 2016).  
As regards the reporting quality found, the mHealth working group set up by the WHO in 
2011 was linked to two recent publications advocating for improved reporting in mHealth 
(Agarwal, Lefevre & Labrique, 2017; Agarwal et al., 2016). This supports our finding that few 
publications referred to mHealth-specific guidelines, although they may have used study-
design-specific guides. We would therefore encourage mHealth study authors to use specific 
guidelines and checklists for reporting interventions. 
Hopefully, increased awareness of the mERA guidelines has a similar effect for adolescent 
mHealth to the improved reporting quality for sexual and reproductive health publications. 
We found few eligible studies for our target conditions, despite their significant contribution 
to adolescent morbidity, and the current adolescent global initiatives (WHO, 2014b). Of most 
concern, is the lack of relevant adolescent infectious disease studies. Notwithstanding the 
regulatory challenges regarding consent of younger adolescents, the relative blind spot for 
their pivotal role in infectious disease transmission needs to be addressed as a matter of 
priority.  
In sum, the research gap for well-reported interventions addressing biological or behavioural 
outcomes persists outside of the sexual and reproductive health field for adolescents. We 
postulate that this is related to the dominance of HIV research and funding in the last two 
decades and the 2011 WHO directive on mHealth for sexual and reproductive health 
outcomes (WHO, 2011). To address the paucity of non-sexual and reproductive health 
outcomes within the mHealth sphere and lack of LMIC representation that we found, it would 
be desirable to have mHealth assessments embedded within large, well-funded, longer 
follow-up clinical trials. The implication of these findings for knowledge transfer to adolescent 
infectious disease using mHealth, may be that it remains too early to conclusively comment. 
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Few studies were reported well, transparently, or by any guideline required to enable 
replication.  
Our study also had limitations. Only five authors responded to email queries for data and 
clarification. Studies rarely reported details of the setting clearly, and it is possible that some 
studies were excluded as they were not explicit in reporting how interventions were 
accessed. Some studies were classified as mHealth, when in fact there was no wireless 
intervention component, merely an assessment by online questionnaire at follow-up, for 
example.We found two RCTS that were registered as clinical trials with NIH or 
clinicaltrials.gov, with clear links to funding. All systematic reviews found were registered 
with PROSPERO, whereas scoping reviews are not eligible for registration at this time. All 
studies pooled in the meta-analysis (n=12) used the PRISMA-P diagram to describe flow of 
study participants from randomization to follow-up, despite the sometimes small numbers. 
5.4 Conclusion 
Overall, the mHealth studies were not well-reported, with unclear health outcomes and 
unclearly defined populations (especially for younger adolescents under 16 years). 
Conversely, the well-reported volume of sexual and reproductive health literature found for 
adolescents has been encouraging. Our study shows that mHealth interventions geared at 
adolescents are being produced; yet few target younger adolescents. The variable reporting 
quality of mHealth publications remains a significant factor limiting knowledge transfer, 
interpretation of findings,and understanding of the settings in which certain interventions are 
effective. 
At this time, the significant focus on systematic reviews may be misplaced for adolescent 
mHealth. In much the same way that we use reporting guidelines and registration platforms 
for systematic reviews, there is a dire need for such tools for scoping reviews (particularly 
those within mHealth) in order to grow an evidence body of standardised work. Duplicating 
research efforts while health outcomes worsen is costly in terms of time, money and the 
wellbeing of young people.  
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APPENDIX 1 FINAL AND INITIAL SEARCH STRATEGY (PUBMED) 
Initial search: 
Set 1 Adolescence 
Adolescent [MeSH] (13-18 yrs.) 
OR 
Young adult [MeSH] (19-24 yrs.) 
OR 
Adolescence OR adolescent OR teenager OR teenage OR teen OR pubertal OR Youth OR 
young adult OR young people 
AND 
Set 2mHealth 
"Telemedicine"[Mesh] 
OR 
Cellular Phone [MeSH] 
OR 
Text Messaging [MeSH] 
OR 
Medical Informatics Applications [MeSH] 
OR 
Reminder Systems [MeSH]  
OR 
Mobile Applications [MeSH]  
OR 
Telemedicine OR Digital health OR Mhealth OR M-health OR eHealth OR e-health OR 
mobile health OR telehealth OR telecare 
OR 
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(Health OR medicine) AND (Mobile based OR Mobile technology OR Text messaging OR 
Text OR texting OR messages OR Messaging OR SMS OR MMS OR Mobile phones OR 
Mobile phone based OR Cell phones OR Cellular phones OR Smartphone OR mobile 
devices OR Mobile apps OR Mobile applications OR Web-based OR Internet-based OR e-
counselling OR portable electronic applications OR telephone-based OR telecommunication 
OR social media) 
AND 
Set 3 Health Promotion 
Preventive Health Services [MeSH] 
OR 
Health Communication [MeSH] 
OR 
Patient Compliance [MeSH] 
OR 
Health education OR health promotion OR patient education OR health communication OR 
peer-to-peer communication OR health behavior change OR health behaviour change 
AND 
Set 4 Immunization 
"Immunization"[Mesh] 
OR 
Immunization OR Immunisation OR vaccination OR immunostimulation OR Immunologic 
Stimulation OR Immunological Stimulation OR Immunological Sensitization OR vaccines 
AND
 62 
Set 5 Tuberculosis 
Mycobacterium Infections [MeSH] 
OR 
TB OR tuberculosis OR mycobacterium Infections 
AND 
Set 6 Infectious Diseases 
Communicable Diseases [MeSH] 
OR 
Infectious Diseases OR communicable diseases 
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Final Search: 
S1  
"Health Promotion" OR "Health Communication" OR "Health Education" OR "Health 
Behavior" OR "Medication Adherence" OR “Patient Compliance" OR “information seeking 
behavior” OR “Health behavior change” OR “patient education” OR “patient compliance” 
S2  
"Telemedicine" OR "Smartphone" OR "Cell Phones" OR "Social Media" OR "Text 
Messaging" OR mHealth OR “mobile health” OR “Digital health” OR ehealth OR “mobile 
device” OR “mobile phone” OR “cell phone” OR SnapChat OR Instagram OR WhatsApp 
OR “web 2.0” OR twitter OR facebook OR "Mobile Applications" OR “short message 
service”  
S3  "Adolescent" OR adolescence OR "Young Adult" OR "Minors"  
S4  
undernutrition OR anaemia OR malnutrition OR suicide OR “mental disorders” OR “mood 
disorder” OR "depressive disorder" OR depression OR "bipolar disorder" OR "substance-
related disorder" OR smoking OR “tobacco use” OR “alcohol use” OR “underage drinking” 
OR injury OR "Road traffic accidents" OR "Traffic Accidents" OR “Unintentional injury” OR 
“Penetrating Wounds” OR Wounds OR violence OR "infectious disease" OR “infectious 
disease transmission” OR "communicable disease" OR pneumonia OR 
bronchopneumonia OR meningitis OR diarrhea OR gastroenteritis OR malaria OR 
tuberculosis OR “human immunodeficiency virus” OR HIV OR immunis* OR vaccine OR 
vaccination OR immunization OR "Reproductive health" OR "Sexual health" OR "Unsafe 
sex  
S5  
“randomized controlled trial” OR “controlled clinical trial” OR “randomized controlled trials” 
OR “random allocation” OR “double-blind method” OR “single-blind method” OR “clinical 
trial” OR “clinical trials” OR "clinical trial" OR singl* OR doubl* OR trebl* OR blind* OR 
placebos OR placebo* OR random* OR “research design” OR “comparative study” OR 
“comparative studies” OR “evaluation studies” OR “evaluation study” OR “follow-up 
studies” OR “prospective studies” OR controlled OR controls OR control OR prospectiv* 
OR volunteer* OR cohort OR “mixed methods” OR “meta analysis” OR “meta-analysis”  
S6  S1 AND S2 AND S3 AND S4 AND S5  
S7  
S6 NOT ( "Qualitative Research" OR "Surveys and Questionnaires" OR “qualitative study” 
OR “qualitative method” OR survey OR “survey method” OR questionnaire )  
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APPENDIX 2 ELIGIBILITY PROMPT TOOL FOR INCLUSION/EXCLUSION 
  
Inclusion Criteria: if ‘NO” to any of these questions, exclude  
 
YES Unsure 
 
NO 
1 Is the intervention accessed on wireless technology, such as mobile phones/ 
smartphone/laptop/PDA? (rather than e.g. desktop, home- or facility-based computer 
etc.)  
   
2 Is the intervention aimed at one of the target conditions? (TB, HIV, SRH, self-harm, 
violence, substance abuse, suicide, depression) 
   
3 Is the study an RCT / MMSD / quasi-experimental / before-and-after trial design?  
(rather than editorial, focus group/ survey / commentary ) 
   
4 Is there a control group receiving standard of care or another mHealth intervention?    
5 Do participants 10-19 years of age make up at least 50% of the sample size?    
     
  
Exclusion Criteria: if ‘YES” to any of these questions, exclude  
 
YES 
 
Unsure  
 
NO 
1 Is there exclusive use of telephone or voice calls as a means of communication?  
(rather than e.g. SMS, social media, website, WhatsApp, Facebook etc.) 
 
   
2 Is any part of the study pending for complete reporting of results?    
3 Is insufficient detail reported for the study to be replicated? (e.g. sample size, effect 
size)  
   
4 Is the intervention targeted at vaccine-preventable disease other than influenza or 
HPV? 
   
5 Do participants older than 19 years make up more than 50% of the sample?    
  
NB. TICKS IN SHADED AREAS SUGGEST EXCLUSION OR DISCUSSION  
 
DATE: _______________ 
FIRST REVIEWER’s INTIALS  □□   
SECOND REVIEWER’s INTIALS  □□  
IN AGREEMENT? YES □ NO / ADJUDICATION □ 
FINAL DECISION:  INCLUDE FOR FULL-TEXT SCREEN □  EXCLUDE □ 
COMMENTS:_______________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________ 
Date:_________
  65 
APPENDIX 3 DATA EXTRACTION FORM 
Author Year Reviewer 
1. General Information 
Date, reviewer   
Reference citation  
Publication type   
Potentially eligible studies 
from the reference list 
Yes (1)   
No (2) 
Notes: 
 
  
2. Study characteristics 
 
Eligibility criteria Location in 
text 
Disease targeted HIV (1)        TB (2)         RTA(3)        
RPH (4)VIOLENCE (5)         
DEPRESSION(6)     SUICIDE (7) 
VPD INFLUENZA (8)    VPD HPV (9) 
pg 
fig 
Location/Language of 
paper 
Location  
WB Classification LMIC (1) 
WB MIC                         (2) 
pg 
fig 
Study type  Specify:  pg 
fig 
Systematic review 
reference  
Yes (1) 
No (2) 
pg 
fig 
Participants (age-ranges / 
proportion of adolescents if 
broader sample) 
10 – 14 years (1) 
15 – 19 years (2) 
Other (3) 
pg 
fig 
Types of outcome 
measures 
Health knowledge (1) 
Risk behaviour (2) 
Medication adherence (3) 
Appointment management (4) on-time or 
increased 
Provider relationship (5) 
Treatment outcome measure (VL, scale) (6) 
Other (7) 
pg 
fig 
 
INCLUDE  
 
EXCLUDE   
Notes: 
 
 
  
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
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3. Characteristics of included studies 
Methods 
 Descriptions as stated in report/paper 
 
Location 
Aim of study   pg 
fig 
 
Study Design 
(specify) 
Cohort (1)                          Mixed Methods (4) 
Cross Sectional (2)           RCT (3) 
Pre-post /quasi-experimental (4)  
 
pg 
fig 
 
 
Unit of allocation 
(by individuals, 
cluster/ groups) 
Individuals (1) 
Clusters (2) 
pg 
fig 
Duration   Start date (recruitment  
End date to last follow-up) 
pg 
 
Ethics approval 
obtained / needed 1   2     3  
YesNoUnclear 
 pg 
 
Notes: 
 
 
 
Quantitative study characteristics 
Population and setting 
 Description Include comparative information for each 
intervention or comparison group if available 
Location  
Population 
description 
 pg 
fig 
Setting 
(including location 
and social context) 
 pg 
fig 
Inclusion criteria    pg 
fig 
Exclusion criteria   pg 
fig 
Method of 
recruitment of 
participants  
 pg 
fig 
Informed consent 
obtained   1   2   3  Yes No Unclear 
  
Notes 
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Participants 
 Description as stated in paper 
 
Location 
in text 
Total enrolled  pg 
fig 
Withdrawal/exclusions    
Age Age range eligible:  
OR 
Age-disaggregated data with at least 50% sample 
between ages 10-19 years: 
 
 
pg 
fig 
Sex   
Location/Access 1 rural     2 urban     3 airtime provided pg 
fig 
Phone/technology 1 Own    2 Shared    3 Study pg 
fig 
Subgroups measured   pg 
fig/table 
Notes  
 
 
 
Outcome measures 
 Description  
 
Location 
in text  
Intervention   
Modality   
Prevalence/Incidence 
of Condition 
  
Comparator (specify 
comparator as SOC or 
another mHealth 
modality, validated?) 
1  Yes                              2 No  
 
Point of treatment 
provision 1 add-on  2 outpatient    3 inpatient      
 
Notes: 
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Risk of bias assessment 
High risk of: Description and assessment 
Selection 
bias? pg 
fig/table 
 
 
1 Yes    2 No   3 Unclear 
Performance 
bias? pg 
fig/table 
 
 
1 Yes    2 No   3 Unclear 
Detection 
bias? pg 
fig/table 
 
 
1 Yes    2 No   3 Unclear 
Attrition bias? 
pg 
fig/table 
 
 
1 Yes    2 No   3 Unclear 
Reporting 
bias?pg 
fig/table 
 
 
1 Yes    2 No   3 Unclear 
Are study 
results valid? 
pg     fig/table 
 
 
1 Yes    2 No   3 Unclear 
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Other relevant information 
 Descriptions/figures as stated  
Key conclusions 
from the authors 
pg 
fig/table 
 
pg 
fig/table 
 
 
 
 
Notes 
pg 
fig/table 
 
 
pg 
fig/table 
 
 
pg 
fig/table 
 
 
pg 
fig/table 
 
 
pg 
fig/table 
 
 
pg 
fig/table 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 70 
APPENDIX 4 SCOPING REVIEW STUDY PROTOCOL 
The impact of mHealth on adolescent global health outcomes: a scoping review of mHealth 
initiatives 
Please refer to Sections 3.1-3.5 of the thesis Methods for a description of the changes between this initial study 
protocol and completed scoping review. 
Background  
HIV, tuberculosis (TB) and malaria collectively account for 60% of the global disease burden 
(WHO 2015 report). A third of the world’s population, about 2 billion people, have latent TB 
infection (LTBI), meaning that they are infected with TB bacteria that are contained by the 
immune system and have not progressed to active disease. HIV co-infection with LTBI 
rapidly accelerates progression to active TB disease, but also complicates diagnosis of TB. 
In 2014, tuberculosis alone killed 1.5 million of the 9.6 million people with active tuberculosis 
disease. Twenty-five percent of these deaths occurred in HIV-positive people, the vast 
majority living in Sub-Saharan Africa (WHO TB report 2015). 
 
This disease burden places immense pressure on health systems in developing countries. 
Prevention of infection by means of an effective vaccine is an important public health tool 
and offers the best hope of eradication (Wiysonge, 2012; Kim, 2012; Cobelens, 2012). 
Globally, immunisation against vaccine-preventable disease (VPD) saves between 2 and 
3 million lives per year (Odone, 2015). There is however not yet a safe, publicly 
accessible vaccine that offers lasting protection against HIV, TB or Malaria. The only 
registered anti-tuberculous vaccine, BCG, is administered at birth and does not offer 
lasting protection against tuberculosis into adulthood (Kaufmann, Hussey & Lambert, 
2010). 
 
Many promising infectious disease vaccines for HIV and TB now target adolescents (Harris 
et al 2016). Some of these vaccines are already in late-stage development, with registration 
anticipated in the next few years (Ginsberg, Ann M. et al., 2016). As adolescents are 
neglected by health systems, the opportunity to shape enduring positive health behaviour 
that reduces chronic disease in later life and assists early diagnosis and reduced 
transmission of infectious disease, is often missed (Viner 2011, Patton 2012). Information is 
therefore urgently needed on how best to communicate health promotion messages to 
adolescents, so that health workers may effectively engage with adolescents to implement 
the vaccines when approved (Patton 2016). 
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Mobile phone technology has become recognised for its ability to improve health service 
delivery through improved communication, education and behaviour change (Gurman, Rubin 
& Roess, 2012).The greatest increase in mobile phone ownership has been in developing 
countries and its potential in reaching vulnerable populations has led to rapid integration in 
health care delivery. This integration of mobile or wireless technology into health systems for 
improved healthcare delivery is known as mHealth (Mechael, 2009). mHealth has been 
identified as an effective tool for improved vaccine implementation (Wiysonge, 2012; WHO, 
2015), as well as for adult infectious disease management through improved adherence, 
visit reminders, education, communication of results, data collection and follow-up care (Devi 
et al., 2015). Adolescents are the group with growing access to wireless technologies that 
include WAP-enabled mobile phones, smartphones, tablets and laptops (Amacizia, 2013). 
With the fastest-growing use of mobile phones globally being among youth, m-Health 
interventions may be especially suited to this group for communication of positive health-
related information (Kata, 2009).  
 
Rationale 
 
Much of the evidence for improved health outcomes using mHealth comes from developed 
countries, and for target groups such as caregivers of younger children, health professionals, 
and adult patients (Free, 2011), while adolescents have been neglected as mHealth 
beneficiaries. Moreover, the same mHealth interventions may not show similar results when 
applied to different health conditions, or in different socio-cultural settings. For example, two-
way short-message service (SMS) that improved adherence to antiretroviral (Mitchell, Pirie & 
Ingram) treatment did not show similar success for TB treatment adherence (Nglazi et al., 
2013). As yet, there remains no clear evidence for the link between mHealth and behaviour 
change or why some interventions work, and others do not (Davis, 2015; Mbuagbaw 2015; 
Aranda-Jan 2014; Labrique 2013).  
 
Unfulfilled infectious disease targets of the Millennium Development Goals have been 
carried through to the Sustainable Development Goals (SDGs) and SDG 3 has prioritized 
infectious disease efforts for developing countries with the hope of eradicating infectious 
disease by 2030 (WHO Global TB report 2015). For the first time in 2016, adolescents have 
been included in the WHO’s updated Global Strategy “because they are central to everything 
we want to achieve and…by helping adolescents to realise their rights to health, well-being, 
education and full and equal participation in society, we are equipping them to attain their full 
potential as adults” (Ban Ki-moon, United Nations Secretary General, quoted in the WHO 
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Global Strategy 2015). 
The period of adolescence, defined as between 10 and 19 years of age (United Nations 
Department of Social and Economic Affairs, 2013), is a highly social age that corresponds 
with waning immunity from childhood vaccination and often-missed booster vaccines for 
VPD such as pertussis and meningococcal meningitis (Amicizia, 2013). Identifying what has 
worked previously for improving health-seeking behaviour for common adolescent conditions 
will be vital for curbing transmission of infectious disease when the long-awaited vaccines 
against TB, HIV and malaria become available to the public. The purpose of this scoping 
review is therefore to examine the state of the evidence for adolescent mHealth success 
globally, in order to gain insights into the types of interventions that work best at targeting 
adolescents for positive health outcomes. These insights will be used to propose a 
framework for the design and implementation of adolescent mHealth infectious disease 
management in low and middle-income countries.  
 
 
Literature Review 
mHealth for infectious disease management 
Mobile phone technology has become recognised for its ability to improve health service 
delivery through improved communication, education and behaviour change (Gurman, Rubin 
& Roess, 2012).The integration of mobile or wireless technology into health systems for 
improved healthcare delivery and health promotion is also known as mHealth (Mechael, 
2009). mHealth may include health information systems, clinical decision-making tools such 
as apps3, reminder services, short message services (SMS) and telephone calls or any other 
wireless communication for the purpose of improving health implementation and outcomes 
(Aranda-Jan, Mohutsiwa-Dibe & Loukanova, 2014; Fortuin et al., 2016). 
 
mHealth has been shown to be effective for a range of improved health outcomes that 
include disease surveillance, health information for patients, supply chain management and 
provider decision aids (Free, 2010; Kalan, 2014; Oyo-Ita, 2016); it has also been shown to 
                                                             
3A mobile application, most commonly referred to as an app, is a type of application software designed to run on 
a mobile device, such as a smartphone or tablet computer. Mobile applications frequently serve to provide users 
with similar services to those accessed on PCs. Apps are generally small, individual software units with limited 
function. (source:  https://www.techopedia.com/definition/2953/mobile-application-mobile-app) 	
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be effective for adult HIV and TB disease management through improved adherence, visit 
reminders, education, communication of results, data collection and follow-up care (Devi et 
al., 2015). Information and communication technology through mobile phones, the internet, 
social networking sites and instant messaging have provided means to an expanded social 
environment, and many young people are at the forefront of adopting these means of 
communication. However, their benefits of communication and entertainment are weighed 
against harmful information, cyberbullying, sleep disturbance and other physical effects from 
over-use (Gore et al., 2011). Owing to its low cost, ease of use, growing mobile phone 
coverage among youth, and ability to deliver health messages directly to the target patient, 
mHealth may be uniquely placed in addressing the adolescent health knowledge and 
behaviour, even in rural areas with poor clinic access. Its great potential in reaching 
vulnerable populations has led to rapid integration in health care delivery, especially in 
developing countries, where mobile phone ownership has grown the most in the last decade 
(Wu & Raghupathi, 2012).  
 
In as much as the growth in mobile phone ownership and wireless coverage is a major 
opportunity for mHealth, its sustainability in developing countries is threatened by a “digital 
divide” (Wu & Raghupathi, 2012). The divide between those rural, older, less affluent 
communities in developing countries and those younger, more urban, living in more affluent 
communities means that those who stand to benefit most from disruptive technologies, are 
least likely to use the technology(Ahmed, 2014; Dorsey, 2016). Despite evidence of 
mHealth’s positive impact upon infectious and non-infectious disease in both developed and 
developing contexts, it remains under-utilised and is rarely scaled to capacity in low and 
middle-income countries (Brinkel, 2014; Hall, 2014; Falzon, 2016). 
 
The role of immunisation in infectious disease management 
Immunisation refers to the planned administration of a series of oral or injectable vaccines. 
Vaccines are substances able to stimulate a protective immune response, in order to reduce 
the effects of infectious illness (Ginsberg, A., 2010).There are countless barriers to effective 
immunisation - among them stigma, access, incomplete vaccine coverage (in the case of 
multiple doses), harmful information about vaccine safety and other context-specific reasons 
(Degeling et al., 2015). When there are too few adequately immunised people in a 
community, it increases risk of infection for the whole community, or “herd” (Agarwal 2015; 
Szilagy 2006), especially for those who are at risk of infection, but cannot be immunised due 
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to pregnancy, allergy or extremes of age (too young or too old), for example.  
Incomplete immunisation, missed boosters, and waning immunity after childhood 
immunisation causing reduced herd immunity, all contribute to the current global resurgence 
in VPD like measles and pertussis. Immunisation programmes linked with other relevant 
health services has potential to improve morbidity and mortality directly, as well as providing 
an opportunity for broader services such as health promotion and screening (Wiysonge et 
al., 2012). Immunisation incentives therefore remain a global priority as a target of the 
Sustainable Development Goals (Asah, 2015). Furthermore, adolescent immunisation has 
been specifically identified as a target with potentially the greatest public health benefits for 
infectious disease management (Agarwal, 2015; Harris 2016).  
 
The role of mHealth for adolescent global health  
The World Health Organisation (WHO) defines “adolescents” as those aged 10–19 years, 
and “youth” as those aged 15-24 years (United Nations Department of Economic and Social 
Affairs, 2013), definitions which this paper will adhere to. Adolescents have been overlooked 
in global health initiatives due to the assumption that theirs is the healthiest period of life 
(Blum, 2004). Adolescents pose unique health systems challenges in terms of coverage and 
positive health knowledge (Viner et al., 2011) and addressing their wellbeing becomes vital 
as this enables independence, completion of schooling with better employment options, and 
healthy relationships (Gore et al., 2011; Sawyer et al., 2012). The transition from 
adolescence into healthy, productive adulthood requires access to health education, quality 
appropriate health services, and supportive home and community environments (Laski, 
2015). In addition, negative health attitudes developed in adolescence (like poor nutrition 
and lack of exercise, road traffic accidents, undetected depression, eating disorders, 
substance and tobacco use, for example) underpin chronic disease and physical disability in 
later life, as well as directly affecting the health and early childhood development of their 
potential children (Patton, 2012; Laski, 2015). 
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Understanding and promoting health behaviour among adolescents is essential because 
they constitute the future health and economic potential of especially low andmiddle-income 
countries (UNICEF, 2002; Wiysonge, 2012). This is especially so in Sub-Saharan Africa 
(SSA) where their number makes up 30% of the population (Dick, 2015), and their wellbeing 
becomes integral to later workforce productivity (WHO Global strategy report, 2015). 
Countries have neglected the future potential of these young people over the past 50 years, 
and need to invest in their improved health and economic development (Das Gupta et al., 
2014). 
Adolescents are the group with growing access to wireless technologies, a trend present 
across the spectrum of per capita income and geo-spatial location (Agarwal et al., 2015). 
Wireless technologies prevalent among adolescents include WAP-enabled mobile phones, 
smartphones, tablets and laptops (Amacizia, 2013).  
With the fastest-growing use of mobile phones globally among youth, m-Health interventions 
may be especially suited to them for communication of positive health-related information 
(Kata, 2009). This may be especially so among the vulnerable group of male adolescents 
whose burden of disease has been least affected by public health initiatives (Viner, 2011; 
WHO 2015). 
What remains unclear is what specific m-Health interventions work best across the broad 
spectrum of mHealth modalities to target adolescents. Other specific mHealth modalities 
such as Unstructured Supplementary Service Data (USSD) or free applications may hold 
more appeal in higher data cost settings than SMS reminders and telephone calls, for 
example, which have previously been shown to improve healthcare appointment attendance 
in adults (Gurol-Urganci, 2013). Though it makes sense that adolescents should prefer web 
2.0 communication social networking platforms such as Facebook and Twitter that allow 
continuous updating (as they are cheap and allow more text characters than SMS, for 
example) there is little evidence to support this, especially for low and middle-income 
countries (Wolfe, 2005). Given the recent proliferation of mHealth initiatives targeted at 
adolescents, it would be useful to examine their successes and failures to understand what 
has worked, and why (Aranda-Jan, Mohutsiwa-Dibe & Loukanova, 2014; Mbuagbaw et al., 
2015). The knowledge gained could potentially facilitate rollout of adolescent vaccines for 
high-burden infectious disease, already in late-stage development, once they are registered 
for use (Harris et al., 2016). 
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Aim 
 
The project aims to determine if the use of mHealth enhances infectious disease 
management among adolescents in low and middle-income countries, and how this 
knowledge may be transferred to the implementation of adolescent immunisation 
programmes, particularly for TB. The aims will be achieved by addressing multiple, related 
research questions using published evidence, grey literature as well as consultation with 
relevant health practitioners:  
1. What specific mHealth intervention modalities appeal to adolescents, and why?  
2. How do the successful modalities differ between developed and developing 
countries, and for infectious and non-infectious disease? 
3. What are the implications of the above for designing and implementing mHealth 
interventions for TB immunisation among adolescents in developing countries? 
 
Methodology 
In order to close the knowledge gap between successful adolescent mHealth interventions 
and their implementation in developing countries, a scoping review will be conducted of all 
relevant primary studies and systematic reviews on mHealth interventions targeting the 
adolescent population. A scoping review is a specific style of literature review, able to rapidly 
and systematically map key concepts underscoring a research area as well as the types and 
main sources of evidence (Arksey and O’Malley, 2005). This knowledge is essential for 
understanding gaps in the evidence base, and scoping reviews are therefore often done to 
determine the feasibility of a full systematic review (Levac, Colquhoun & O'Brien, 2010). The 
framework for conducting scoping reviews is described in the literature, and the mandatory 
steps of refining the research question (Stage 1), literature review and selection (Stage 2 
and 3), data extraction (Stage 4) and concise reporting of results (Stage 5) will be followed 
(Arksey and O’Malley, 2005; Armstrong 2011). Given the breadth of the topic to be covered, 
the optional Fifth Stage of consultation with health experts may also be followed (Levac, 
Colquhoun & O'Brien, 2010). The findings will be considered in the context of adolescent 
infectious disease management, particularly tuberculosis immunisation. 
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Study participant eligibility 
Primary studies used in this scoping review will include adolescents of any gender, location, 
or ethnicity with access to a mobile phone or wireless device in any country, used for a 
health-related outcome. Ethics approval is not applicable, as no participants will be recruited. 
 
Type of intervention  
We will examine mHealth interventions targeting the most common adolescent conditions, 
as identified by most recent Global Burden of Disease Study (Mokdad et al., 2016). The 
GBD tracks the burden of age-and gender-specific causes of death and morbidity in 188 
countries, across environmental (air pollution, sanitation, handwashing), behavioural (alcohol 
and drug use, unsafe sex, road accidents, interpersonal violence), mental health and 
metabolic causes, for a period of twenty years (Mokdad et al., 2016). mHealth interventions 
for the 4 highest causes of disability and death in adolescents (road injuries, mental health 
disorders and suicide, violence, selected infectious diseases and iron-deficiency anaemia) 
will be targeted. 
 
mHealth modalities may include health information systems, clinical decision-making tools 
such as apps, reminder services, short message services (SMS) and telephone calls or any 
other wireless communication for the purpose of improving health implementation and 
outcomes (Fortuin et al., 2016).  There will be no limitation placed on the type of mHealth 
modality, as this scoping review aims to identify the evidence for mHealth interventions for 
adolescents as well as any differences between successful developing- and developed-
country interventions. 
 
Outcomes  
 
Commonly-used outcome indicators such as mortality, morbidity, and cost to health systems, 
may not be available in published evidence due to the very recent focus on adolescent 
wellbeing and given that age-aggregated data is limited (Dick 2015; WHO 2015). An 
assessment of improved health outcome will thus be done by grouping mHealth intervention 
outcomes into descriptive outcome categories, such as self-actualisation, self-reported 
health knowledge, effect on socialisation, community positioning, and mediation of improved 
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relationships between health-care-workers and adolescents (Petit, 2012). The descriptive 
mHealth outcome categories will be reviewed against the quality of evidence supporting 
them.  
The primary outcome of this review will be an assessment of whether there is improved 
management of the commonest global adolescent conditions when using mHealth. The 
knowledge gained from the literature will be used to consider how mHealth implementation 
programmes for infectious disease management in developing countries may be designed. 
This will be done by examining the evidence profile for the descriptive outcome categories of 
mhealth modalities targeting the commonest adolescent conditions in order to answer the 
research questions (What specific mHealth intervention modalities appeal to adolescents, 
and why? How do the successful modalities differ between developed and developing 
countries, and for infectious and non-infectious disease? What are the implications of the 
above for designing and implementing mHealth interventions for TB immunisation among 
adolescents in developing countries?). 
Secondary outcomes include identifying further research needs, and identifying opportunities 
and barriers to scaling up mHealth interventions in developing countries.  
 
Search Strategy 
An overview will be conducted of primary studies and systematic reviews published in peer-
reviewed journals from January 1990 until January 2017, with no language limitation. The 
following electronic databases will be searched: Pubmed (NLM), Scopus, CINAHL, 
EBSCOhost, Africa-Wide, psychINFO, Web of Science (Thomson Reuters), Cochrane 
Library (including Cochrane Central Register of Controlled Trials (CENTRAL), Academic 
Search Premier, Communication and Mass Media Complete, Computer and Applied 
Sciences Complete and NHS Health Technology Assessment Database. The studies will be 
selected using predefined search terms comprising both free text word and medical subject 
heading (MeSH) for Pubmed (Appendix 1), and adapted appropriately for other databases.  
The terms will describe m-Health, the adolescent population, and the most relevant 
adolescent health promotion interventions.  
The reference lists of identified studies will be hand searched for relevant articles and a 
citation index such as Scopus will be used to identify relevant articles being cited, and their 
references. This will be expanded until a point of saturation is reached. Unpublished sources 
will also be evaluated in the form of conference proceeding and abstracts, institutional 
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websites including the World Health Organisation (WHO), and other international working 
groups for clinical evidence guidelines.  
The search strategy will be developed with a Health Sciences Information specialist, and 
updated before the final search. 
 
Inclusion and exclusion criteria for study and systematic review selection 
 
Conventional systematic reviews risk excluding large bodies of evidence due to stringent 
inclusion and exclusion criteria (Leon, Schneider & Daviaud, 2012). This scoping review will 
aim to include as much relevant evidence for policy makers, disease control planners and 
health practitioners to understand and effectively implement adolescent mHealth 
interventions in their particular context.  
We will include studies and systematic reviews where the mHealth intervention is the 
primary component being evaluated. Studies with additional non-mHealth measures (for 
example, health visits or counselling) that differ between the control and intervention groups, 
will be excluded. 
Included studies will target adolescents themselves, and not schoolteachers, caregivers or 
other health providers. Studies should report clearly on the mHealth modality used, and state 
study objectives a priori. For inclusion of systematic reviews, at least one primary study 
should be a randomised controlled trial, and contain a transparent assessment by the 
authors of quality and risk of bias in order to strike a balance between methodological rigour 
and the broad review parameters required to effectively map the literature. 
 
Review selection 
 
All articles identified by the search will be screened by title and abstract and the full-text 
drawn if relevant, or more information is needed. All relevant full-text articles will be saved in 
Endnote software manager and all duplicate material will be deleted. The process of 
identification, screening, and inclusion of relevant studies will be depicted by flow diagram 
(PRISMA, 2009).
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Data extraction and management 
 
A data extraction form will be piloted on four selected reviews or primary studies, with 
reviewers meeting to discuss insights and refine the data extraction tool. Data will be 
extracted independently in duplicate by the author and her primary supervisor and verified by 
a third adjudicator (her co-supervisor) if no consensus can be reached.In the case of multiple 
reviews covering the same population and all meeting inclusion criteria, the most 
comprehensive or recent review will be used. One reviewer will enter the final data into 
statistical software package (Cochrane Collaboration Review Manager Version 5.1). Data 
will be crosschecked by a second reviewer independently before analysis.  
The data will be presented in a summary of findings table showing the number and type of 
included studies; participant details; countries in which the primary studies were done; 
mHealth modality and wireless technology targeted; reporting quality regarding allocation 
concealment, blinding of outcome assessors, loss to follow-up, and other sources of bias. 
Key conclusions, possible limitations and knowledge gaps will also be presented in tabulated 
form. The measures of effect per intervention will be provided as a forest plot with 95% 
confidence intervals and I-squared value for heterogeneity 
 
Dealing with missing data 
The authors of primary studies will be contacted telephonically or by email when study 
designs, methods, outcomes or statistical data reported are unclear. If the data has not been 
obtained despite multiple attempts, it will be noted in the narrative.  
 
Assessing methodological quality 
Poor quality of included primary studies and reviews adversely affects the reliability, and 
thereby the transferability of results outside the clinical trial environment (Guyatt 2011; 
Coello-Alonso 2016). This scoping review will thus implement rigorous methods of quality 
assessment throughout the review process. The Cochrane Risk of Bias Tool (Cochrane 
Group 2011, Higgins 2011) will be used to assess methodology of primary quantitative 
studies, and report the quality as being of high, medium, low, or unclear quality. Qualitative 
studies will be assessed by the Joanna Briggs Institute Qualitative Assessment and Review 
Instrument (JBI-QARI 2011). The AMSTAR (Assessment of methodological quality of 
systematic reviews) tool will review 11 criteria for detection of bias in systematic reviews. 
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Reviews may be scored as high quality (8-11 items), moderate quality (4-7) and low quality 
(3 or less items). 
 
The quality assessment forms will be piloted on four selected studies. One reviewer will 
independently assess the studies, which will be checked by the second reviewer. Quality 
assessment discordance between the two initial reviewers will be adjudicated by the third 
reviewer.  
 
 
Data Synthesis of Quantitative Studies 
 
Meta-analysis, the statistical process of pooling comparable results to determine effect size, 
will only be done if the primary studies are similar enough as regards participant, 
intervention, comparator and outcome elements. It is unlikely that meta-analysis for most 
quantitative data obtained will be possible, due to varying outcomes. Forest plots will thus 
illustrate the range of effect sizes for the different mHealth modalities; even if the 
standardised effect size cannot be obtained for meta-analysis, all effect sizes with 95% 
confidence will be provided in the narrative.If any required data is unclear or incomplete, the 
authors will be contacted for clarification. 
 
A summary of findings (SOF) table will be used to show the findings for each primary 
outcome. One reviewer will group findings from primary studies into broad descriptions 
related to improved adolescent health outcomes. The second reviewer will then verify that 
the narrative of the primary studies matches that of first reviewer’s SOF table descriptions.  
 
The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) 
approach advocated by the GRADE Working Group, will be used to assess the quality of 
evidence for all included primary studies (Guyatt et al., 2008). This will be reported in the 
evidence profile of the SOF table for each outcome description as being of high, moderate, 
low or very low quality.  
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A sensitivity analysis will be conducted by including only studies assessed as low risk of bias 
in a repeat meta-analysis, where possible. This will allow assessment of the sensitivity of the 
results to overall quality of the data. 
 
Heterogeneity of studies included in reviews will be assessed before inclusion in the meta-
analysis. A cut-off I-square value of 50% will render them excluded from the pooled meta-
analysis as an indication of high heterogeneity. 
 
Subgroup analysis may be conducted across the following variables: 
• Risk- high or average 
• Location- rural or urban 
• World Bank definition of low or middle-income country 
 
 
Dissemination of findings 
 
Following completion of the scoping review, the results are planned for publication in a 
scientific journal, and as a chapter of the student reviewer’s Masters thesis. 
The review protocol will be registered with PROSPERO before commencement.
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Discussion 
The proposed scoping review may advance scoping review methodology as an effective, 
systematic research approach to address complex questions that could otherwise not be 
answered by the explicit approach of a systematic review. As it is able to effectively and 
quickly map the literature, it will help to identify further gaps in the existing mHealth evidence 
base, and prompt further research. Finally, this review has the potential to inform the design 
of a relevant, accessible adolescent immunisation mHealth intervention, thereby including 
adolescents and developing countries as stakeholders in the global health arena. 
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